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Abstract
The purpose of this study was to determine how different scanning techniques on 4DCT
images impacted the perceived target volume, and how this in turn affected the dose
calculation and dose distribution to the target volume. Acquired 4DCT datasets were
reconstructed to form Maximum Intensity Projections (MIP), Average Intensity
Projections (AIP) and free breathing datasets. Comparisons of the resultant CT number,
mass density, point dose values, and dose distribution were made for the different
datasets. These comparisons showed how different scanning techniques used to
manipulate the 4DCT dataset affect treatment planning and dose calculation for
radiotherapy for a moving tumour volume within the lungs.

While the CT numbers for the AIP, MIP and the free breathing datasets were different,
the resultant density values for the moving target volume showed similar results for the
MIP and free breathing images. For the MIP dataset, the target volume density ranged
from 1.03 g/cm3 to 1.04 g/cm3. For the Free breathing dataset, the volume density
ranged from 0.90 g/cm3 to 1.02 g/cm3. The AIP dataset showed lower target volume
density, ranging from 0.50 g/cm3 to 0.86 g/cm3.

Dose to a point was both measured and calculated for comparison as well. The
calculated point dose on the different image types was calculated using the Pinnacle3
treatment planning system, while an ionization chamber was used to measure dose to a
point in the phantom. Results showed lower calculated dose to a point for all the image
types, in comparison to measured point dose values. However, a more clinically
relevant assessment would be to compare the dose distribution to the target volume.

Comparisons of the dose distribution for the different image types (the AIP, MIP and
free breathing) compared to the dose distribution averaged across the 8 phases of the
4DCT dataset was made. Comparisons were also made with increasing magnitude of
motion to identify if the results were the same as the magnitude of motion increased. As
motion increased, it was found that while MIP images were acceptable for dose
calculation and treatment planning, the AIP images became less suitable.

Results obtained here are based on simulated motions on a simplified phantom.
Although simplified geometries and motions were used in this study, the results provide
some guidance when applying AIP or MIP related 4DCT treatment planning procedure
for small tumours moving within a heterogeneous medium.
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1. Introduction
1.1

Cancer

Cancer is the irregular growth of abnormal cells that divide in an uncontrolled state.
Cancers can occur in various parts of the body and are able to migrate from the primary
location to other parts of the body through blood or the lymphatic systems. According to
the Australian Institute of Health and Welfare [1] in 2017, an estimated 134,174 people
will be diagnosed with cancer and that 47,753 people will die from it. The Australian
Burden of Disease study finds that 19% of the total disease burden in Australia is due to
cancer alone [2]. In Australia, aside from non-melanoma skin cancer, the most common
cancers are Prostate, Breast, Colorectal (bowel), Melanoma and Lung cancer [2].

Interestingly, younger people tend to have different cancers from that of older people.
According to the Australian cancer database, the more commonly diagnosed cancer that
afflicts people under the age of 24 are Leukaemia, Lymphoma and Brain cancer. People
who are between ages 25 to 49 tend to be afflicted by Breast cancer, Melanoma, and
Colorectal cancer. People who are 65 and over tend to be afflicted by Colorectal,
Prostate, and Lung cancers [1].

Treatments for cancers are typically through radiation therapy, chemotherapy and
surgery, used in an optimal combination specific to each patient. Chemotherapy is
typically used to treat cancers that have spread throughout the body. Strong drugs are
introduced into the body that are targeted at rapidly dividing cells, which is perhaps the
main characteristics of cancer cell. This treatment is typically done intravenously where
medication is slowly introduced into the body through a catheter through a large vein.

1.2

Radiation Therapy

Radiation Therapy, also called radiotherapy, refers to treatment of cancer by irradiating
the cancer cells with precise high doses of radiation. This method can be used to treat
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both primary and advanced cancers. High doses of radiation are delivered to the tumour
volume, where upon dose deposition, the ionizing radiation will cause damage to the
DNA of the cancerous cells [3]. If the cells are damaged enough beyond repair, the
cancerous cells can then be broken down and removed from the body. Today,
radiotherapy can be delivered by many means, but more generally, it can be categorized
into external radiotherapy as well as internal radiotherapy. Internal radiotherapy refers
to delivering radiation from within the body through a radiation source implanted into
or near the tumour volume. External beam radiotherapy refers to a means of delivering
radiation dosage from an external source outside of the body to irradiate the cancerous
cells. A common delivery of external beam radiotherapy is through a medical linear
accelerator (commonly known as the LINAC). Radiation beams from linear accelerators
are usually modulated and shaped as they are delivered to the patient.

Radiotherapy treatments require careful treatment planning before dose delivery.
Firstly, patients with the tumours are imaged with medical imaging techniques like a CT
scan. Based on the CT images, treatment plans are created where the tumour and vital
organs can be delineated and the dose to the various structures can be calculated. This
involves using specific treatment planning systems on computers to simulate and
calculate the appropriate amount of dose to the tumour within the patient, to assess the
viability of the treatment plan. As such, the accuracy of the acquired image is of
importance in the treatment planning process.

Tumour motion is a challenge that needs to be managed during radiotherapy. Motion
like respiratory motion can cause blurring artifacts in the images [4]. The motion can be
large and unpredictable which can lead to inaccurate target delineation [5]. Improper
motion management can lead to organs at risk being irradiated, or the tumour volume
not being fully irradiated.

1.3

4 Dimensional Computed Tomography

Four-Dimensional Computed Tomography(4DCT) used in conjunction with Stereotactic
Body Radiation Therapy (SBRT) is an excellent means to treat patients with tumours in
regions of greater motion. SBRT can be defined as a form of external beam
radiotherapy that delivers high dosages of radiation in fewer fractions to an accurately
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localized target site [6]. 4DCT images consist of multiple CT slice images taken
throughout a single respiration cycle of the patient, from end-inspiration to endexpiration. The unique aspect of this compared to conventional CT scanning is that
4DCT incorporates both spatial and temporal information of the tumour motion. This
imaging technique of 4DCT enables capturing of tumour motion more precisely and
accurately, such that highly conformal radiation therapy in the form of SBRT can be
delivered to patients. Through 4DCT images, the tumour motion is observed in relation
to the respiratory motion of the patient. Additionally, it is also possible to observe how
surrounding healthy tissue affects the motion of the tumour with 4DCT images. As
such, 4DCT imaging is typically used in treatment for cancers located in or near to the
heart, liver, breast, and especially in the lungs.

Precise treatment planning is essential such that sufficient radiation is delivered to the
target volume, while simultaneously avoiding healthy normal organs at risk (OARs).
The choice of image used for target delineation and dose calculation during treatment
planning is very important as different image reconstruction methods will produce
varying outcomes. Outlining the various volumes on every single image in the 4DCT
image set will be very time consuming. Instead, various image types can be constructed,
to reduce the work load of the radiation oncologist. These different image types will be
discussed in the later sections. It would thus be interesting to study how the different
methods of image reconstruction affects the CT numbers, target delineation and the
dose calculation as well during treatment planning to find the most optimal image to use
for treatment planning.

1.4

Aims

Due to respiratory motion, treatment planning is especially important to ensure that the
motion of the tumour volume is accurately captured. Using 4DCT imaging techniques,
the motion of the tumour in a single respiration cycle can be observed from start
inspiration to end exhalation.

Based on the 4DCT dataset, new image types like

Maximum Intensity Projection (MIP), and Average Intensity Projection (AIP) images,
can be formed to be used for target delineation and dose calculation. Treatment planning
on these reconstructed datasets would be significantly less workload for the radiation
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oncologist during the treatment planning process, compared to planning on all phases of
the 4DCT dataset.

There are 3 main aims in this thesis, which will be discussed in various chapters;

1) What impact does the 4DCT dataset representation (i.e.: MIP, AIP, or a single
4DCT phase) have on CT number?
The initial aim is to study how different reconstructed images based on the 4DCT
dataset, like the MIP, AIP, or a specific 4DCT phase, affect the resultant CT number of
the image. This is important because dose calculation is dependent on density as derived
from CT number. More importantly, the aim is to determine if each of the reconstructed
images accurately represents the physical density of a moving target volume, and if the
density representation of the tumour volume changes as the magnitude of motion
increases.

2) What impact do different CT numbers derived from reconstructed 4DCT
datasets have on dose calculated to a point?
The second aim is to study the accuracy of dose delivery to a point within the moving
target on the different reconstructed images. Since dose calculation is CT number
dependent, and the reconstructed images have varying CT numbers, the resultant
calculated point dose is of interest. The accuracy of the calculated point dose can then
be compared to the measured point dose under the same motion settings in the phantom.

3) What impact does the different CT numbers derived from reconstructed 4DCT
datasets have on dose calculated to a moving target volume?
The third and final aim is to observe the dose distribution to the target volume as
calculated on the different reconstructed images. In the treatment planning process, the
dose distribution to the entire target volume, not just dose to a point, is used to assess
the suitability of the plan for the treatment of the patient. Since 4DCT is primarily used
for imaging tumours involving motion, it is important that dose calculation on the
reconstructed image is accurate even as the magnitude of motion of the tumour or
breathing motion is increased. This study involves comparison of the dose distribution
to the target volume based on treatment planning on the MIP, AIP and free breathing
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image compared to the 4DCT image set to determine the equivalency of the dose as
magnitude of motion is increased.
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2. Literature Review
2.1

Stereotactic Ablative Radiation Therapy(SABR)

Stereotactic Ablative Radiation Therapy (SABR) also known as Stereotactic Body
Radiation Therapy (SBRT) is widely used for treatment of early stage or stage I lung
cancers and oligometastatic cancers. SABR is a method of delivering radiation therapy
to the patient at very high dose per fraction, but in fewer fractions, compared to
conventional radiotherapy. As such, it is sometimes also known as Hypofractionated
SBRT treatment. Conventional external beam radiotherapy (EBRT) typically delivers
comparatively much lower dose fractions at around 1Gy to 4Gy per fraction, with 1.8Gy
to 2Gy being the most common. The typical number of fractions range between 10 to 30
fractions [7]. With SABR however, the doses per fraction are typically greater than
6Gy, ranging anywhere from 6 – 30Gy per fraction, with number of fractions being
between 1 to 5 fractions [7]. In this thesis, the term SABR and SBRT will be used
interchangeably.

When higher dose of radiation per fraction is prescribed to the patient, a higher
biological effective dose (BED) is also delivered to the patient. The BED, refers to the
true biological dose delivered to the tumour volume, but is not actually biologically
equivalent in dose. The BED is a dose value determined by a combination of the dose
per fraction, the total dose, and the

𝜶
𝜷

ratio, which is 3 for normal tissues and 10 for

tumours in general. However, this is not the case for all tumour types, for prostate
cancer the

𝜶
𝜷

ratio is significantly lower according to a study by Brenner & Hall [8].

The significance of this lower

𝜶
𝜷

ratio is that appropriately planned hypofractionated

treatments like SABR would be a suitable course of treatment for patients as there
would be a high level of tumour control while simultaneously also reduced acute
morbidity [8].
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According to Casamassima et al [9], who studied the different equivalent BED for
pulmonary neoplastic nodules, for proper radioablation of the pulmonary neoplastic
nodule, SABR with high dose fractions and thus high BED is necessary. In another
study by Mehta et al [10], that studied the radiobiological rational for dose per fraction
escalation in non-small cell lung cancer (NSCLC), a higher BED delivered within a
shorter period, like SBRT, achieves better local control of the lung cancer. In another
retrospective study by Onishi et al [11] of 257 patients with stage I NSCLC in a
Japanese Multi–institutional study, hypofractionated high dose stereotactic radio
therapy, similar to SABR, with high BED, is a feasible curative treatment for patients
with stage I NSCLC.

There have been multiple studies, [9, 10, 11, 12, 13],that have concluded that delivering
high doses of radiation per fraction such as SBRT is an effective procedure for the
treatment of early stage cancers, such as stage I NSCLC lung cancers. SBRT provides
high local control as well as reduced treatment time. To ensure proper and successful
administration of the treatment, target delineation is essential to ensure that highly
conformal dose is delivered to the target while healthy normal tissues are spared. This is
especially important in the case of SBRT treatment as this method requires very high
radiation dosage per fraction to be administered to the patients. Treatment margins have
to be within millimeters accuracy with well-defined target definition [7]. Additionally,
strict motion management is essential as well, especially since one of the major factors
to account for with lung tumour cancer, is respiration.

In summary, motion management and proper target delineation during treatment
planning is essential to deliver the highly conformal SABR treatment to patients
successfully without complications.

2.2

Computed Tomography

Computed Tomography (CT) images are 2D cut plane images formed as a result of
highly filtered kilovoltage x-rays being transmitted through the body of the patient at
multiple angles around the patient on to an array of detectors. Through a series of data
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processing, these transmissions are converted into images which can be used to identify
the different organs of different densities in the patient.

On the CT scanner, the x-ray source is located directly opposite an array of detectors in
a donut like structure called the gantry. The patient is positioned on the moveable table
(sometimes known as couch) that goes though the gantry as seen in Figure 2.1. The
detector effectively measures the x-ray intensity transmitted (It) through the patient.
Unattenuated x-ray beam (I0) is also measured by a reference detector. A single slice
image is produced when the x-ray source and the array of detectors forms a full 360°
rotation around the patient. This single slice image contains density information about
all the structures being imaged.

The obtained raw data from the detector is pre-processed. This is a necessary step
before image reconstruction such that the dependency of the image is primarily
dependent on the patient’s anatomic characteristics and less on the machine-dependent
variables of It and I0 [14]. The relationship between the two variables is given by:
𝐼𝑡 = 𝐼0 𝑒 −𝜇𝑡
t is the thickness of the patient along the ray, while µ is the average linear attenuation
coefficient along the ray. Using the natural log, ln, and rearranging the equation:
𝐼𝑡
ln ( ) = 𝜇𝑡
𝐼0
This preprocessing step results in the t variable ultimately cancelling out, producing the
average linear attenuation coefficient µ used in the CT reconstruction algorithm.

After all data has been pre-processed, it then undergoes CT reconstruction methods to
produce a CT image. Filtered backprojection is the preferred reconstruction algorithm.
As the method’s name suggests, this algorithm back projects, or reverses the image
acquisition process. The attenuation information collected as the x rays transmit through
the body, is smeared back along the same x ray path on to an image matrix. This process
is repeated for all the rays that have been transmitted through the patient.
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The resultant image is the cross-sectional 2D CT image of the 3D structure. Each image
pixel displays the average x-ray attenuation property of the structure being imaged.
Areas of high attenuation, where less x-rays are transmitted, will appear lighter (dense
structures) while areas of low attenuation have more x rays being transmitted and will
appear darker (less dense structures).

2.2.1 Axial/ Sequential Static scan
Early CT scanners employed a step-and-shoot mode. During the image acquisition
period, the x-ray tube is turned on and 360 degrees of projection data is acquired. The xray tube is then turned off while the patient is moved to acquire another slice scan. This
process is repeated until the number of desired scans are acquired. This method is also
coined the term step and shoot CT due to this process. During the image acquisition
period when the x-ray tube is turned on, the table is completely stationary [14]. This is
also known as axial or sequential CT scans.

2.2.2 Helical Scan
The introduction of slip ring technology resulted in the advent of helical CT scanners.
Helical CT scanners rotate continuously around the patient in a spiral motion as the
patient is gradually moved through the gantry on a patient couch at a constant speed to
obtain the CT images. This effectively results in the x-ray tube moving in a spiral or
helical fashion around the patient. This allows CT images to be acquired continuously
as the patient table moves inwards through the gantry. Interpolation of data is required
to estimate the image between the collected and rebinned data [15]. The interpolation is
necessary such that smooth cohesive images are formed as the patient translates through
the gantry. In terms of acquisition time, helical scans are more quickly acquired than
static axial scans. As seen in Figure 2.1, the patient is gradually moved through the
gantry as helical scans of the patient is continually taken.
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Figure 2.1 Shows how helical scans are taken as the scanner rotates while the patient is simultaneously moved
through the gantry [16]

An important parameter that should be considered with helical scanning is the pitch. For
a conventional helical CT scanner, the pitch is defined as the distance travelled by the
table per 360° rotation divided by the collimator width [15]. The beam width, which is
affected by the collimator width also determines the image thickness. Therefore, the
pitch can also be understood as the ratio of the distance travelled by the table per
rotation to the slice thickness. The pitch affects multiple factors such as the image
quality, scan time, and radiation dose to the patient.

When the Pitch = 1, this is ideal where the images are formed exactly where the last one
started with no gaps or overlaps in the images or x ray beams (comparable with
contiguous axial CT). A pitch < 1 results in over–scanning. This means that there is
over lapping in the x ray beams and thus CT images. While the image quality may be
better, the trade-off is increased scan time as well as increased radiation dosage to the
patient. A Pitch > 1 means there will be gaps where parts of the structures are not
irradiated. Partial scanning occurs and more interpolation is necessary. This results in
faster scan time and less radiation dose to patient. This also means that there is less
patient motion throughout the scan.

In general a pitch of 1 to 1.5 is considered acceptable to be used [14]. The method of
helical scanning is much faster than the static sequential scan. The disadvantage
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however is that there is potentially loss of information during scan acquisition, which
leads to more reconstructions artifacts than static axial scans.

2.2.3 CT number consistency
CT numbers are normalized integer numbers used to represent the attenuation value
calculated for each pixel of the CT image produced. It is normalized to the attenuation
properties of water. It is measured in Hounsfield Units (HU) and is acquired using the
equation:

CT number (HU) = 1000

μ − μwater
μwater − μair
(eq 1)

Where µ refers to the average linear attenuation coefficient of the structure measured,
while 𝝁𝒘𝒂𝒕𝒆𝒓 and 𝝁𝒂𝒊𝒓 are the linear attenuations of water and air respectively. The µ
values are all taken at the same energy. The numbers can range from about -1000 HU to
+3000HU [14]. Air has a CT number of -1000 HU while water will have a CT number
of 0 HU at STP (Standard Temperature and Pressure).

CT numbers describe the physical attributes of the structures and how it influences
Compton scattering [14].Compton scattering is the dominant x-ray interaction in CT
imaging. This is reflected in the contrast of the CT image (the different shades of grey
of the CT image). The Compton scatter cross section depends on the electron density
𝑍

𝜌𝑒 , where 𝜌𝑒 = 𝑁 𝐴 where N is Avogadro’s number (6.023 x 1023), Z is the atomic
number and A is the atomic mass. Different structures in the body like soft tissue, lungs,
and fat constitute of different proportion of carbon, hydrogen, nitrogen and oxygen.
Hydrogenous (Z = 1, A = 1) tissues like fat is well visualized on CT images [14]. This
results in the different structures having different CT numbers. The electron density ρe
(cm-3), measured in number of electrons per unit volume, is different from the physical
mass density ρ (g/cm3), measured in mass per unit volume.

In Table 2.1 approximate CT numbers for various tissue types are listed. A range of CT
numbers have been reported for various tissue types. This could be due to multiple
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factors such as different tissue compositions and thicknesses within the patient.
Different CT scanners also provide CT numbers of varying values. Measuring the CT
number is an important part of the diagnostic workup and can lead to more accurate
diagnosis. As an example, the amount of calcification on pulmonary nodules can be
determined from the CT image by measuring the CT number [14].
Table 2.1 The Table shows the approximate CT numbers of various structures within the body [17].

Structure

CT Number(HU)

Bone

700 to 3000

Soft Tissue

-300 to -100

Blood

35 to 40

Muscle

40

Kidney

30

Fat

-50 – 100

Human Lung

-700

To accurately assess the CT numbers from a CT scanner, a CT–density phantom with
various known tissue densities representing the different areas of the body like lungs,
water, soft tissue, bone, etc, can be scanned. When the phantom is scanned and the CT
number (HU) is obtained, a relationship between the various tissues and the CT
numbers can be established. The CT Electron Density Phantom by Gammex [18], is
designed for this purpose, and can be used to convert the CT numbers obtained in
Hounsfield units (HU) to electron densities for accurate calculation of the dose
distributions. The Solid Water Phantom as seen in Figure 2.2 can be equipped with 16
different inserts with interchangeable Tissue Mimicking Materials (TMM). The 16
inserts consist of 13 different materials with a wide range of electron density values that
can be used to obtain a CT–to–density table necessary for calibration. Thus, an accurate
relationship between CT number and electron densities can be established.
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Figure 2.2 The Gammax RMI Solid Water CT Electron Density Phantom with the 16 different inserts of different
electron density values used for calibration [18].

During treatment planning, a CT electron density phantom like the one described above
is used to calibrate the CT number (HU) and tissue density relationship. Once CT
images of the calibration phantom are scanned, they are then exported onto treatment
planning systems like Pinnacle3 [19]. On Pinnacle3, regions of interest (ROI)s, including
the inserts with the various different electron densities can be contoured. Pinnacle3 will
then provide the average CT number (HU) for the various ROIs and the contoured
inserts. The physical mass density (g/cm3) of each insert of the phantom, as well as the
relative electron density to water, 𝜌𝑒𝑤 is known. Only mass density is recorded on
Pinnacle3, corresponding to the CT numbers obtained. Thus, a CT number calibration
table can be formed. Pinnacle3 is unique, such that the CT number scale goes from 0 to
4000 instead of starting from -1000 (CT number for air). This is to avoid signed
integers. Therefore, the final 1000 units need to be added to obtain the final CT number
in Hounsfield Units.
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Figure 2.3 Example of the CT number (HU) to Density (g/cm3) calibration table used in Pinnacle3

The detectors on the CT scanner measures the physical attenuation experienced by the
phantom, and thus, physical density is used in the CT to Density calibration table
instead of electron density. An example of the CT to Density calibration table can be
seen in Figure 2.3. Additionally, a dual energy CT is needed to determine the different
attenuations to obtain the electron densities [20], but this is more time consuming.
Instead, a correction can be applied to convert the physical mass density(g/cm3) values
to electron density(cm-3) values for dose calculation. This step is necessary as the
electron density (cm-3) determines the dose deposited in the area due to Compton
interactions.

Therefore, based on the CT number, it is possible to then derive the properties of the
material, based on the photon tissue interaction [21]. This information can then be used
in CT based dose calculations [21].

2.3

4D Radiotherapy

The gold standard definition of 4D Radiotherapy according to Paul Keall [22], is the
explicit inclusion of the temporal changes in anatomy during imaging, planning and
delivery of radiotherapy. For organs that involve a lot of motion like lung radiotherapy,
the greatest challenge is the respiratory motion which affects both organ and target
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motion. While the greatest motion is in the craniocaudal direction, it is not one
dimensional and is subject to movement in lateral and or anterior/posterior direction as
well. Therefore prior to treatment, imaging of the treatment site is very much necessary.
4DCT is usually the best imaging technique where motion is involved, complementary
to SBRT or SABR treatment. It is the acquisition of a sequence of CT image sets over
consecutive segments of a breathing cycle [22]. In using 4DCT for imaging, the motion
of the tumour during respiration can be captured with greater accuracy and fewer
artifacts, leading to better dose conformality during treatment planning. This simulation
technique will be further discussed in the next sub chapter. The highly conformal dose
distribution is designed to target and kill tumour cells while sparing surrounding healthy
tissues. Before actual radiation therapy is delivered to the patient however, treatment
planning and or treatment simulation is very much necessary. Using techniques like
SBRT in 4D radiotherapy for lungs, with proper target delineation, high conformal dose
can be delivered to the tumour while healthy tissues are spared.

2.3.1 Four-Dimensional Computed Tomography (4DCT)
While the discussed 3DCT methods above are excellent and still widely used, a few
problems or artifacts arise especially when motion is involved. Patient movement,
especially involuntary motion such as respiration or organ movement can cause motion
artifacts where the structures imaged would be blurred and or distorted, resulting in
images that do not correctly reflect the actual structure. CT numbers may be affected as
well due to beam hardening [23], and partial volume effects [23]. 3DCT images consists
of only snapshot images at random breathing phases.

4DCT or 4–Dimensional Computed Tomography is a more recent and useful method of
imaging that has been introduced to account for motion. It is especially useful when
imaging areas of significant motion like the thoracic area where the lungs and heart are
located. 4DCT imaging is a simulation technique, where the 4DCT images are an
extension of 3DCT techniques with the benefit of defining the location of a moving
organ at a specific time. 4DCT images are a collection of multiple sets of 3DCT images
tagged with breathing signals along the patient’s long axis at multiple phases of a
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complete respiration cycle [24]. The acquired 3DCT images tagged with the breathing
signals are sorted retrospectively according to the correct breathing phase or motion
amplitude to provide a full set of 4DCT image [24].The respiration cycle includes the
start of the inhalation to the end of the exhalation. Effectively the 4DCT images show
the anatomical position and shape of all the structures and how it moves and changes
throughout the respiration cycle.

4DCT is used commonly for non-small cell lung cancer (NSCLC) target delineation in
conjunction with stereotactic ablative body radiotherapy (SABR), also known as
stereotactic body radiation therapy (SBRT). As 4DCT images provide more
anatomically accurate images with less blurring and fewer motion artifacts, using these
images for target delineation of volumes in SABR is preferred. It should be noted that
the 4DCT imaging technique can also be used in with other forms of non-stereotactic
treatment fractionation as well.

The image acquisition can broadly be categorized into cine mode and helical mode.
Cine Mode involves acquiring images using static/axial CT scanning methods while
simultaneously acquiring patient specific breathing signals. With this method, for at
least one respiration cycle, the CT scanner continuously acquires images of the patient
with the patient table being completely stationary. Once the respiration cycle is
completed, the patient table is moved a distance through the gantry and images are
taken for the following respiration cycle. The distance moved is equivalent to the
detector(s) width. This process is repeated for the required number of respiration cycles
necessary to cover the desired region to be imaged.
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Figure 2.4 shows how the 3DCT images are used to form 4DCT image set based on breathing cycle in Cine mode.
Images can be sorted according to breathing phases as shown in this figure, or by motion amplitude.

The breathing signal can be generated based on using external respiratory tracking tools.
This usually involves markers being placed on the patient, like a marker block and an
infrared camera as with the Varian RPM system to track the respiratory motion [25],or
pressure sensitive pneumatic belts that derives the abdominal motion, like with the
Anzai(AZ-733V) belt. These systems work to track respiratory motion of the patient
and sort the images properly according to the retrieved signal. The Varian RPM system
is discussed further under the subtitle gating with external respiration signal.
Each of the highlighted region in yellow in Figure 2.4 represents a 4DCT image set,
consisting of sets of 3DCT image taken at multiple phases of a single respiration cycle,
at a stationary position. The 4DCT scan is complete when the entire structure is imaged,
and the images can be combined to reflect the motion of the organ or tumour
corresponding to the breathing patterns of the patient.

Helical mode involves acquiring CT images by helical CT scanning with a small pitch
in conjunction with the patient specific breathing signal. This method is quicker and
results in less radiation to patient as the patient is continuously moved through the
gantry of the CT scanner to obtain the images. This method requires data interpolation
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between the data taken. This may result in slight inaccuracies as compared to images
acquired in cine mode, however the acquisition time is also quicker via helical CT
scanning. Helical CT scans require an additional breathing cycle scan so that all
locations have complete breath cycles data for data interpolation [13]. According to
[14], to ensure that there is no missing data when obtaining images by helical means, a
data sufficiency condition (DSC) is necessary such that at each table location, data is be
acquired for the duration of one respiratory cycle, plus the duration of data acquisition
for image reconstruction. 4DCT is a method of imaging used in many cases today for
treatment of lung cancers [6, 25, 26, 27, 28, 29],especially where SABR of stage 1
NSCLC cancers are involved.

2.4 Respiratory Motion Management techniques
While 4DCT imaging is ideal for capturing the motion of a tumour, to obtain good
quality images, motion management techniques are necessary to reduce motion artifacts
and decreased dose conformality during treatment. 4DCT images are more prone to
artifacts when the respiratory cycle or breathing patterns of the patient are irregular [31].
Additionally, the motion the tumour obtained during 4DCT imaging and treatment
planning, may not be the same as the tumour motion during treatment delivery. To
overcome this, patients are coached to breathe such that a consistent respiratory motion
can be produced, resulting in better image quality.

In SABR, to ensure that the high radiation dosage is minimized to healthy lung tissue
volume, motion management is a very important factor to consider before delivering the
dose. Intrafraction motion, that is involuntary motion of the patient such as respiratory
motion, has to be accounted for before dose delivery. Interfraction motion on the other
hand refers to set up errors that occur when setting up patients for treatment from one
fraction to the next fraction. That is, patient set up may differ slightly each time.

With lung cancer, of course the main component is the respiratory motion. The lungs
functions by ventilating the lungs through inhalation and exhalation. The diaphragm
contracts during inhalation, forcing air into the lungs, increasing the volume and
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reducing the density of the lungs. This causes motion in the superior inferior (SI)
direction of the body, while the rib cage motion causes motion in the lateral and
anterior–posterior (AP) direction to occur. This effectively causes motion in normal
healthy tissues, as well as the tumour itself. Every patient will have varying breathing
patterns pertaining to the period, amplitude, and direction of motion of the tumour. It is
often difficult to visualize and monitor tumour directly using fluoroscopic or portal
images during treatment. This prompts the necessity of using surrogates to monitor the
tumour motion. The surrogates are usually used to provide observation of respiratory
motion through the diaphragm or chest wall motion, which is an indicator of lung
tumour motion. However, caution must be taken, as this surrogate tumour motion, may
not accurately reflect true tumour motion [32].Therefore, individualized respiratory
motion must be assessed prior to patient treatment.

2.4.1 Respiratory Gating
Respiratory gating can be generally classified between gating with an external
respiratory signal, and gating with an internal respiratory signal. This method usually
involves only administering radiation treatment at a specific phase of the patient’s
respiratory signal where the radiation beam is “gated” on, while at other phases, the
radiation beam is “gated” off. The patient’s respiratory motion can be observed through
internal fiducial markers implanted into or near the tumour, or by external respiratory
signal.
Gating with Internal Fiducial Markers.

Gating with internal fiducial markers involve implanting small gold fiducial markers of
about 2mm in diameter, into or around the tumour in question. To properly track the
motion, a minimum of 3 fiducial markers are necessary. The fiducial marker positions
are then tracked using stereotactic kilovoltage x-ray imaging systems in combination
with automatic detection software [32]. Radiation treatment is delivered when the
position of the fiducial markers are within range of the planned position on the
stereotactic imaging cameras [32]. The Fiducial markers can be inserted percutaneously
through needle gauges into or around the tumour with the help of CT imaging.
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However, fiducial markers tend to migrate or move around slightly and can even be
dislodged from their original location. In some cases, it can even lead to pneumothorax,
that is, a situation with a collapsed lung where air leaks from the lung into the chest wall
cavity. In a study of 28 patients who have had fiducial markers implanted [33], 67% of
the patients developed pneumothorax and 22% required a chest tube. Some fiducial
markers were also found to have migrated into both the pleural and airway space. In
another study by Mallarajapatna et al [34], of about 122 cases, it showed that fiducial
markers can migrate into the pleural cavity, the peritoneum, and even in the lung or
viscera. Two patients had moderate hemothorax. Therefore, caution should be taken
when using internal fiducial markers.

A more successful and less risky method is to place the fiducial markers via
conventional and electromagnetic navigation bronchoscopy (ENB) [35]. This technique
was originally designed for assisting biopsies of intrapulmonary nodules. It does not
require needle gauges puncturing percutaneously to place the fiducial markers, and thus,
a significantly lower risk of complications occurring by pneumothorax or bleeding. CT
images of the lungs and the bronchial tree are taken such that the ideal path to use when
inserting the probe is known. The ENB thus utilizes electromagnetic fields that
encompass the entire thorax region to detect and guide the endoscope or catheter
through the bronchial tree, to the lungs, and to the region of interest [35]. To confirm
that fiducial markers are properly implemented to the area or region interest,
fluoroscopy is used to ensure proper marker placement. Inserting fiducial markers via
conventional or ENB allows for optimized therapy planning as well as reduced risk of
complications [35].

Gating with External Respiration Signal

Gating with external respiration signal is less invasive compared to internal fiducial
markers. Prior to radiotherapy treatment, gated CT scans are obtained. The tumour
motion is tracked by observing the respiratory motion, by means of external respiration
signal. The most common method currently to monitor tumour motion and obtain
breathing signal is by using the Varian Real–Time Position Management

TM

(RPM)

system [25]. This system involves using mainly, a predictive filter, an infrared camera,
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and a marker block (an external surrogate), which is a rectangle box with reflective
markers (in the form of dots) to track the patient’s motion.
The marker block is placed on the patient’s abdominal area, where it rises and falls as
the patient breathes. The external rise and fall of the abdominal area reflects the
movement of the patient’s organs and tumour within the treatment field [25]. The
position chosen should reflect the maximum AP respiratory induced motion [32].The
infrared camera tracks this respiration motion by tracking the marker block in 3
dimensions (vertical, longitudinal and lateral). The infrared camera is composed of a
video camera attached below a circular array of LEDS that emit infrared light. Since the
markers are calibrated a distance apart, the absolute motion in the perpendicular plane to
the camera will be captured. The computer contains a software that detects the peaks
and amplitudes of the respiratory signals and assigns relative breathing phases based on
these amplitudes [36].The predictive filter monitors and predicts the patient’s breathing
pattern [25]. As the camera tracks the movement, a pattern is established and thus a
trace can be produced. The predictive filter acts by predicting the patient’s breathing
pattern and continuously verifies that the pattern is being followed. If the pattern is
changed or interrupted, the predictive filter detects the change and the RPM system
stops the beam during treatment [25]. The RPM system displays the motion amplitude
and phase through a graphical user interphase [36].

With the help of the Varian RPM system, a trace of the respiratory cycle can be
produced, and CT image acquisition can be acquired either prospectively, or
retrospectively. Prospective gated CT imaging is a process in which images are acquired
only at a specific phase, or the gating window, during a respiratory cycle as specified by
the user. In a process known as retrospective CT imaging however, images are acquired
throughout all phases of the respiratory cycle and are sorted accordingly.

The Varian RPM Respiratory Gating technology enables synchronization or correlation
of the tumour position and the patient’s respiratory signal [36]. The process of gating
enables users to define a specific window wherein processes can be turned on or off
within that window. During treatment, the RPM system is connected to the computer
linked to the accelerator, allowing users control or an automated trigger to the
accelerator to turn on at a predefined gating window [37] and off when not within the
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window. Problems arise however as there are uncertainties when deriving the internal
tumour position from surrogates. The actual tumour position and marker can vary inter
and intra fractionally [38], where the surrogate tracked by the gating system, does not
correspond to the time dependent target position [32]. To ameliorate this, a minimum of
30 seconds of imaging data should be digitally recorded simultaneously with the
measured respiratory trace. Should there be a time delay of greater than 0.5 seconds
between the two measurements, correction should be applied when setting a gating
interval [32].

2.4.2 Slow CT Scan
Performing slow CT scans is a method used to obtain images to define the entire range
of motion of the tumour volume. The CT scanner is operated very slowly where
multiple CT scans are obtained and averaged over the entire respiration cycle. If CT
scans are obtained helically, a slow gantry rotation speed is necessary such that tumour
motion is properly captured during image acquisition. This method can be easily
implemented on most CT scanners without any additional cost or equipment. Patients
can also breathe freely throughout the imaging process. However, one drawback is the
loss of image resolution, where the exact tumour shape and shape of the surrounding
structures will be blurred in the slow CT image. This will lead to larger errors in target
and healthy tissue delineation [36]. Additionally, slow CT scanning requires a longer
imaging time, which results in an increased dose to the patient. While Slow CT scans in
general help show the extent of the tumour motion, standard CT scans are still necessary
to determine the boundaries of the different anatomies involved.

2.4.3 Breath Hold Techniques
Another method that has been introduced, to deal with respiratory motion is obtaining
breath hold CT images. This method, as the name suggests, requires coaching of
patients to voluntarily hold their breath when a scan is taken. However, not all patients
are able to undergo breath hold CT scans as some may not be healthy enough to hold
their breath for the required amount of time [39]. However, compared to the earlier
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mentioned slow CT scan, if breath hold CT scans are properly obtained, there will not
be blurring caused by motion. Breath hold techniques are often applied to maximum or
moderately deep inhalation phases, or at the end of normal exhalation. This ensures
better reproducibility of the tumour position. Breath hold techniques employing
datasetss based on both end inhalation and end exhalation can be used to gauge the
amplitude of motion of the tumour volume [30]. However, tumour position observed
with breath hold techniques does not always correspond to the position observed with
free breathing techniques due to the different respiratory muscles used in both methods,
and any tumour lag that occurs during free breathing CT scanning is not seen with
breath hold techniques [32]. Active Breathing Control (ABC) is one method of
producing breath hold CT images. This device consists of a digital spirometer that
measures the respiratory trace, which is connected to a balloon valve. The patient
breathes normally through the spirometer, and after taking preparatory breaths,
instructed to reach a specific lung volume. The balloon valve is then inflated for a predefined period of time, simulating the patient’s breath hold [30]. This is usually for
about 15 to 20 seconds. During treatment, the patient’s breathing for this 15 to 20
second period of time is “held”, while radiation treatment is administered. The radiation
beam is stopped after that period of time, allowing patients to breathe normally until the
ABC is activated again.

While breath hold techniques are less suitable for lung cancer patients, they are suitable
for the treatment of breast cancers as reduced radiation dose is delivered to nearby
OARs like the heart [40]. During breath hold, the heart is pushed down, away from the
radiotherapy fields, reducing risk to healthy OARs without affecting resultant delivered
dose to the cancer in the breast region [41]. Voluntary breath hold is the most costeffective breath hold technique as it reproducibility as well as cardiac sparing effects are
comparable [41]. This technique effectively reduces treatment related toxicity to the
patients, that is, reduced toxicity to the heart [40] and surrounding healthy tissue.

2.4.4 Real Time Tumour Tracking
Real time tumour tracking is another means of motion management which, tracks the
tumour’s position continuously as radiation treatment is administered to the patient.
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This involves identifying the tumour’s position in real time, anticipating the tumour
motion and location throughout the treatment time, allowing for time delays when
repositioning the radiation beam with the help of MLCs, and adapting the dosimetry to
allow for motion of the tumour and healthy anatomy [32]. Real time tracking of the
tumour involves imaging via fluoroscopy, imaging of fiducial markers or tracking of an
active or passive signaling device implanted into tumours. For accurate tracking, the
imaging should be done at a high frequency of several images per second, to ensure
accurate tumour location. This information is transmitted to the beam delivery system.
Time delays need to be accounted for between image acquisition, read out, processing,
and repositioning of the radiation beam through MLCs on the LINAC. Adaptive filters
can be applied to account for up to 200ms in system delays, but accuracy tends to
degrade with longer delay intervals [32].

Real time Tumour tracking is used by a robotic radiosurgery system, Cyberknife. Using
a combination of implanted fiducial markers for tumour motion tracking synchronized
with x-ray imaging, a small linear accelerator attached to a robotic arm will move to
many non-coplanar positions, determined by a treatment plan. With treatment nozzle
moving and targeting in synchrony with the moving fiducial markers, radiation is
continuously administered to the tumour site.

2.4.5 Motion management with 4DCT
In terms of lung cancer and accounting for respiratory and tumour motion, 4DCT, as
described in a previous section, is ideal in tracking the tumour motion as well as
producing accurate images of the healthy surrounding anatomy. Based on 4DCT
images, the tumour volume position as well as the amplitude of motion can be identified
for treatment planning [33]. Breath hold CT techniques can be employed to obtain
4DCT images, however free breathing CT is more commonly practiced when acquiring
4DCT images [42, 43, 44, 45, 46]. Images are acquired retrospectively, that is, acquiring
images are continuously acquired along the longitudinal length of the patient at every
phase of the breathing cycle, to then be sorted either according to the amplitude of the
respiratory motion, or phase of the respiratory cycle.
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2.5

Motion Artifacts

Artifacts are usually an error or a distortion to the image that is not representative of the
actual structure being imaged [47]. This means that on the CT image, there would be a
discrepancy between the CT numbers of the reconstructed image and the actual
attenuation coefficient of the actual structure being imaged [47]. Artifacts degrade
image quality which could lead to errors in target delineation during treatment planning,
and thus errors in actual treatment.

Motion artifacts are a major and a common occurrence in conventional 3DCT images.
Motion artifacts are due to patient factors (such as respiration which causes organs to
shift), as well as target related factors (such as the location and size of the tumour) [48].
Motion artifacts lead to images appearing smeared, distorted, or a combination of both.
Structures contained in the thorax region tend to move periodically in the craniocaudal
and anterior posterior axes, with a period of ~4 seconds with amplitude of motion being
in the order of a few centimeters (cm) [49]. Many studies [28, 49, 50, 51, 48], have
reported that the true anatomical position is not reflected when imaged due to motion,
causing a need to add an extra margin during target delineation. According to Jiang [24,
38], if the CT scan speed is slower than the target motion, the target image will appear
smeared. If the CT scan speed is the same as the target motion, the target position and
shape will be distorted. However, if the CT scan speed is faster than the target motion,
the target position and shape will be captured at an arbitrary phase.

While not as prevalent, motion artifacts are known to affect 4DCT images as well [46,
51, 52, 31]. 4DCT images account for motion where the spatial anatomical position of
organs at risks (OAR) and tumours are known with relative accuracy. Problems arise
when the tumour motion is large, or when the patients have irregular respiratory motion
leading to CT images being tagged incorrectly before being sorted. This results in
geometric distortions artifacts on the CT images [53].

Additionally, artifacts can also occur when there is under-sampling of data. When
4DCT images are taken, by helical methods, interpolation of data between the spirals is
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necessary. Large motion within a brief time can cause under-sampling of images [46],
resulting in more interpolation, and thus more uncertainty, leading to artifacts reflected
on the images. Therefore 4DCT helical scanning requires a small pitch to ensure that
oversampling occurs to prevent too much unnecessary interpolation.

Another factor which potentially affects 4DCT artifacts is the way in which 4DCT
images are binned to be reconstructed. When 4DCT images are acquired, they are sorted
or binned typically by two methods, amplitude binning or phase binning based on the
breathing signal. Amplitude binning sorts the CT images acquired based on the
amplitude of motion, and thus, requires a strong correlation between the respiration
signal and the tumour motion for accurate 4DCT images to be formed. Sometimes due
to baseline shifts or the uneven breathing pattern, this could lead to missing CT slices,
which results in artifacts by amplitude binning [54]. In phase binning, images are
binned into a set number of phase bins, typically 8 or 10 phase bins, equally spaced in
time. The phase bins correspond to distinct phases in the respiration cycle. Larger
motion with a short period could result in under-sampling, which would cause more
artifacts in phase binned 4DCT images [46]. In a recent study conducted by Shieh et al.
[54], comparing the two respiratory binning methods, it was found that amplitude
binned images provided better image quality in capturing the respiratory motion than
phase binned images. Regardless, both methods of image binning are still used in
practice today for 4DCT imaging.

2.6

4D Treatment Planning.

4D treatment planning is defined as treatment plans designed on CT image sets obtained
for each phase of the breathing cycle [22]. The first part of 4D planning is acquiring the
4DCT image. Based on the acquired 4DCT images, the various structures can then be
identified and delineated.

Accurate target delineation and organs at risk (OAR) definition is especially important
in treatments like SBRT as this treatment is designed to deliver very high dosage per
fraction to the patient. As mentioned before, motion is a major factor to consider, and it
is important that the entire volume of the tumour including its motion is considered
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before radiation dose is delivered. In the thorax, the major OARs are lung parenchyma,
heart, central airway, oesophagus, the spinal cord, the brachial plexus, chest wall, and
skin [55]. Target and OAR delineation can be contoured and defined on a single image,
and using deformable image registration, the same contouring can be applied to all other
images in the different phases of the respiratory cycle [56].

Deformable image registration, is a tool used to map a single moving voxel of the CT
image onto a new position of the same voxel on another CT image taken at a different
phase of respiration [22, 56]. The resultant contouring will show how the shape or
anatomy changes or deforms at different stages of the respiratory cycle. Matching the
voxels also allows visualization of the dose at each phase of respiration [22]. Some
algorithms that are commonly used are the finite element method, large deformation
diffeomorphic image registration, and optical flow technique. The resultant effect
should be a set of 4DCT images with the tumour and OARs structures properly
contoured in all phases of the respiration cycle.

Once this is set up, a treatment plan can be made based on the CT images. So far the
4DCT images that have been defined are snapshot images acquired either in helical or
Cine mode. There are other types of 4DCT images as well that are commonly used for
treatment planning.

Maximum Intensity Projection image (MIP) is an image that

represents the highest density or pixel value encountered along the viewing ray in the
4DCT image set. This translates to each pixel of the MIP images displaying pixel values
of the brightest (most dense) object along each ray of the projection image [50]. The
choice of using MIP image for treatment planning would be better when identifying
high contrast objects like lung tumours [22].

Another type of 4DCT image is the Average Intensity Projection (AIP) image. This
image represents the average density or pixel value encountered along the viewing ray
in the 4DCT image set. Each Pixel of the AIP image displays the average value for all
the equivalent pixels in the dataset of the object along the ray of the projection image.
The resultant image, in the case of a moving object, displays the entire range of motion
of the tumour volume. Relative to MIP images, the borders will appear thicker with
lower contrast, but less noisy images [57].
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Physicists also use what is known as the Mid-ventilation image. This method requires
the reconstruction of a single 3DCT scan from the 4DCT dataset. This image reflects
the anatomical and tumour position, at its time–weighted average position of the entire
breathing cycle [42, 58]. The resultant image represents the tumour at its center of
gravity, in all directions of movement, including anterior/posterior and cradio-caudal
direction [45, 59]. This image is chosen at the mid ventilation time percentage, which is
defined as the time at which the tumour is closest to the time weighted mean position
[42]. Mid Ventilation CT, is an improvement in terms of a reduction in error margin
[45]. The study by Khamfongkhruea et al. [42] concluded that using the mid ventilation
concept with the tumour in a mean position, allows for reduced margins [45] during
treatment planning, leading to more conformal irradiation, reducing the volume
irradiated [60].

The benefit of using the above 4DCT image type is that it reduces the workload.
Defining and contouring on a single set of images like the MIP image dataset or the AIP
image dataset, is much less time consuming than contouring for multiple phases, with
multiple sets of images [61]. There have been many studies conducted where different
image types are compared to one another to determine the best image to use for
treatment planning and dose calculation. Multiple studies [27, 30, 61, 62, 63], have
come to the agreement that the MIP image dataset is reliable for target delineation for
the gross tumour volume of stage I lung cancers, as it clearly highlights the entire range
of motion of the tumour volume. However, it is also suggested [61] that MIP images are
not suitable for tumours that are attached to, or intersect any part of the diaphragm. In a
recent study [65], it was found that 4DCT MIP is useful for establishing the mean
amplitude of tumour motion before SBRT treatment, however, maximum amplitude
tends to be underestimated during actual SBRT treatment, and thus caution must be
taken when determining the various margins during treatment planning, especially in the
lower lobe region of the lungs.

While MIP images are preferred for target delineation, AIP images seem to be more
favorable for dose calculation [26, 30, 42]. There is however also a study that suggest
AIP images are good for both target delineation and dose calculation [61]. In the study
[61], that compared treatment planning based on MIP, AIP and free breathing CT
images, they found that dosimetric characteristics of the AIP plans are similar to that of
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the free breathing image. They also found that MIP images are prone to overestimate
and underestimate the target volume when the tumour volume is close to denser tissues.
Additionally, free breathing images are also prone to greater image artifacts than AIP
images. It was thus concluded in that study [61], that AIP image is suitable for both
target delineation and dose calculation. Table 2.2 shows a summary of the more
commonly used images reconstructed from the 4DCT image set used in treatment
planning for patients.
Table 2.2: A table showing some of the different types of images that can be reconstructed based on the 4DCT
images

4DCT Image type

Description
Image set that represents the highest intensity or highest

Maximum Intensity

attenuation value of the 4DCT image set. Images are reliable

Projection (MIP)

for target delineation [26, 30, 44, 58].
Image set that represents the average intensity or average

Average Intensity

attenuation value of the 4DCT image set. Images are favoured

Projection (AIP)

for dose calculation [26, 30, 42, 61].
Image that represents the time weighted average position of
the tumour volume. Treatment planning with this image type

Mid-Ventilation Image

leads to improvement in reduction of error margin [45].

One of the first steps of treatment planning, is to define the structures in general,
including organs at risk OAR and the tumour volumes. During target delineation, it is
important to outline the volumes properly and accurately. The International
Commission of Radiation Units and Measurements (ICRU) has published report 50,
where they have defined multiple volume types in which doses are to be prescribed and
delivered. The main volumes defined prior to treatment, are the Gross Tumour
Volume(GTV), and the Clinical Target Volume (CTV). While performing treatment
planning, Internal Target Volume(ITV), The Planning Target Volume (PTV), Organs at
Risk(OAR), Treated Volume (TV), and Irradiated Volume (IR), are defined.

The GTV refers to the palpable visible extent and location of the malignant growth. The
CTV is defined as the tissue volume that contains the GTV and this volume needs to be
treated with an adequate dose level to ensure proper treatment [65]. The PTV
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encompasses the CTV, and accounts for all possible geometric variation with regards to
the beam size selection such that all the prescribed dose is completely absorbed by the
CTV [63]. In ICRU report 62, the internal margin (IM) is introduced to account for
positional and size/shape changes of the CTV. The setup margin(SM) is also introduced
to account for variations in the patient beam positioning. ( 𝐶𝑇𝑉 + √(𝐼𝑀)2 + (𝑆𝑀)2 )
effectively makes up the PTV region. In ICRU report 62, the Internal Target Volume
(ITV) is also introduced, which is defined as the summed volume of CTV and IM (CTV
+ IM), and is located within the PTV. The Treated Volume (TV) is the treatment
planned volume to receive the dose selected and specified by the radiation oncologist.
The TV encompasses the PTV. The Irradiated Volume (IV) is the tissue volume that
receives a dose considered significant relative to normal tissue tolerances. These
Volume definitions are standards that are widely used and widely accepted. Figure 2.5
shows a representation of the different volume definitions used during treatment
planning for the patient. Table 2.3 shows a summary of the definition of each delineated
volume.

Figure 2.5 A representation of the definition of the different volumes during treatment planning

Since tumour motion is a major source of uncertainty in defining the GTV, the ITV is
thus necessary to obtain a spatially correct volume for the entire volume of the moving
tumour. Using a single set of images like AIP or MIP images to represent the various
volumes is much less time consuming than delineating the target on each phase of the
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ten or eight breathing cycles. While in literature there have been mixed opinions about
the best image to use for target delineation, mostly between MIP or AIP images,
regardless of the image type used, proper target delineation is very important to ensure
conformal radiation and sparing of normal healthy tissues.
Table 2.3 The table summarizes the volumes used when contouring the various volumes during treatment planning
[64]

ICRU report (50 and 62) Description
volume guidelines
Gross Tumour

The palpable visible extent and location of the malignant

Volume(GTV)

growth.

Clinical Target

The volume that contains the GTV that needs to be treated

Volume(CTV)

with an adequate dose level.

Internal Target

The summed volume of the CTV and the Internal margin to

Volume(ITV)

account for physiological involuntary motion. (ITV+CM)

Planning Target Volume

The volume that encompasses the CTV, accounting for

(PTV)

geometric variations. (ITV+SM)

Internal Margin(IM)

Volume to account for physiological involuntary motion of the
patient, causing CTV motion.

Setup Margin(SM)

Volume to account for patient setup variation such as patientbeam positioning.

Treated Volume(TV)

Volume that receives the dose as specified by the radiation
oncologist to achieve the purpose of the treatment.

Irradiated Volume(IV)

The tissue volume that receives a dose that is considered
significant compared to normal tissue tolerance.

Organs at Risk (OAR)

This are healthy nearby organs that are susceptible to
radiation, that also act as constraints

Proper treatment planning and motion management is essential before radiation
treatment is delivered to the patients. Radiation treatment, especially treatments like
SBRT that utilizes high radiation doses per fraction requires careful planning such that
maximum dose is delivered to the patient while simultaneously avoiding normal healthy
tissues or OARs. 4DCT imaging methods are favourable when imaging tumours in
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motion as it would be able to properly capture the tumour motion, with fewer artifacts.
However, care must be taken such that a suitable image type is chosen during treatment
planning for target delineation and dose calculations. While the different image types of
MIP or AIP or even a random phase in the 4DCT image can be used for treatment
planning, depending on the purpose and site of the tumour volume, the most suitable
image to be used might vary between sites. The choice of image to use for target
delineation and dose calculation could be different as well, however careful
consideration should be taken such that there is not excessive workload necessary
during treatment planning. To deliver precise conformal dose to the patient, careful
treatment planning is necessary such that cancerous tumour cells can be eliminated and
healthy tissues are spared.

CIRS Dynamic Thorax Phantom
The phantom of choice that is used for this study during 4DCT acquisition and
treatment planning, is the CIRS Dynamic Thorax Phantom. This phantom provides an
accurate representation of the composition, shape, and density of an average human
thorax. It is designed to also provide and simulate various complex 3D motions that
mimic lung motions in the average patient.
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Within the phantom are two lung equivalent lobes. Within one lobe is a long detachable
lung equivalent rod with a small cylindrical slot where a spherical tumour target and/ or
a dosimeter can be placed. Various types of rods are available to allow for use with
different imaging techniques as well as dosimeters. The lung equivalent rod is attached
to a motion actuator box that has the capability of simulating movement in three
different axes to simulate target motion [66]. The motion includes inferior/superior
motion with a maximum of 50mm, anterior/posterior motion with a maximum of 10mm,
and left/right movements with a maximum of 10mm, or a combination of various of the
motion [67]. As seen in Figure 2.6, the motion of the target motion within the lung
equivalent rod is illustrated.

Figure 2.6 representation of the target motion within the lung equivalent rod [66]

52

The range of motion in any direction is user specific. As the rod is lung equivalent, it is
radiographically invisible, and simulation of motion will only show motion of the
spherical target and or dosimeter. As such target motion of the tumour can be easily
monitored during treatment planning.

Surrogate motion is also provided by using a platform attached to the actuator box as
seen in Figure 2.7. This allows the phantom to simulate the movement of the chest wall
or the diaphragm, depending on how the platform is positioned. Target and surrogate
motion are both independent of one another and is controlled by CIRS Motion Control
Software. Maximum surrogate motion is 50mm. The minimum cycle time is 1
second/cycle while maximum cycle time is unlimited[59].

Figure 2.7 CIRS Phantom Actuator box. The left positioning simulates Chest wall motion while the Right side
simulates Diaphragmatic motion[58]

CIRS Motion Control Software.
The CIRS Motion control software allows control of the CIRS Dynamic Thorax
Phantom. It allows user to define the desired motion in multiple directions that simulate
the motion of a typical patient, all from a laptop with the software installed.

The software allows users to operate the phantom by allowing the user to define
different wave forms, cycles, phase shifts and amplitude of motion for the phantom. As
seen in Figure 2.8, the software provides real-time graphic display of the target as well
as surrogate motion parameters. Users are allowed to start, pause, and stop motion at
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any time, which makes it easy for users to conduct both dynamic and static scans on the
phantom [66].

Figure 2.8 CIRS Motion Control Software GUI which allows users to input multiple parameters to simulate desired
motion in the phantom.
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3. CT number constancy
3.1 Introduction
CT images are cross sectional images formed based on x-ray transmissions or projections through
the body. The CT image reflects the electron density of the structures or tissues imaged within the
body or phantom. The CT image is composed of a matrix of pixels, where each of the pixel on the
CT image, corresponds to a specific CT number. The CT numbers are measured in Hounsfield Units
(HU). The CT number is used by CT scanner to describe how much radiation is attenuated to that
point or by that structure, relative to water. This value is thus highly dependent on the attenuation
coefficient of the material, which in turn is dependent on the density and atomic number (Z) of the
material being imaged. Knowing the value of this, and comparing it to known CT numbers, we can
identify the structure being imaged. The CT numbers for air at STP is known to be -1000 HU, while
for water, it is at 0 HU.

A more detailed explanation of how the CT image is formed, and how the CT numbers are acquired,
is explained in the earlier Literature Review chapter. Once the CT number from the CT scanner is
obtained, they can then be converted to the electron densities, which can then be used for calculation
of the dose distribution to the volume. Therefore, the accuracy of the CT numbers obtained from the
CT scanner has an impact on the accuracy of dose calculation to patient tumours and OARs.

In this study, 4DCT images are acquired during free breathing from the CT scanner, where images
are binned according to 8 different phases following the respiration cycle. Based on the acquired
4DCT images, Maximum Intensity Projection (MIP), and Average Intensity Projection (AIP) are
formed. Treatment planning on every image of all 8 phases of the 4DCT image set can be time
consuming, and as such, various image reconstruction methods are implemented to reduce the
workload. The MIP image is formed based on the maximum intensity or pixel of all phases of the
4DCT images, projected on to a new image set. Similarly, AIP images show the average intensity or
pixel of all phases of the 4DCT images. This study involves comparisons of images from MIP, AIP
and from the 23% phase of the free breathing 4DCT dataset. The choice of 23% phase is to represent
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the free breathing dataset at approximately midway between two extremes of the respiratory motion.
As seen in Figure 3.1, where images are binned into 8 different phases, 10% phase corresponds to
peak exhalation (and the start of inhalation), and the 47% phase corresponds to approximately peak
inhalation(and the start of exhalation).

Figure 3.1 A representation of how the 8 phases of the image sets are binned according to the breathing signal.

On the various images, the density or the representation of the tumour volume will be very different.
For example, MIP images will show a clearer, well defined tumour volume throughout the range of
motion. The AIP image however will show a blurred image, with a less well-defined tumour volume.
Therefore, the resultant CT number between the various image types would be different as well. It is
expected that the AIP image will have lower CT number, compared to the MIP, and 23% phase
image. This is because some lung volume, which is of lower density and thus CT number will be
averaged during the image reconstruction process as well.

CT numbers can be measured and used to distinguish between the healthy and infected tissues.
However, CT scanner manufacturers recommend that unless the distinction or contrast is large, the
CT number alone should not be used to differentiate between the tissue type [68]. CT numbers are
quickly acquired during the treatment planning process. In this study, Pinnacle3 is used for treatment
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planning. Regions of interests (ROIs) are contoured on the CT image. Each voxel on the CT image
has a unique CT number, and an average CT number will be calculated and assigned for the entire
contoured ROI. The CT number is CT scanner specific. A look up calibration table is available on
Pinnacle3 as seen in the earlier chapter, in Figure 2.3, that directly converts the acquired CT number
(HU) into physical density (g/cm3). This lookup calibration table is specific to a CT scanner and
operational energy. Therefore, if images are taken at different times or with different CT scanners,
there will be variations in the CT numbers as well. Based on the values thus, the physical densities
(g/cm3) can be converted to electron density (cm-3), necessary for dose calculation. Therefore, to
ensure accurate dose calculation, it is important that the acquired CT number is also accurate.

This chapter will focus on evaluating the accuracy of the CT numbers obtained based on the various
reconstructed images from different 4DCT image set, and how accurate they are as CT numbers will
affect dose calculations. Planning on the reconstructed image instead of every phase of the 4DCT
image set will potentially reduce the workload of the radiation oncologist in the clinical setting.

3.2 Aim
When structures are imaged on CT scanners, the resultant CT image is a representation of the
densities or linear attenuation by the structures being imaged. Each pixel of the CT image represents
a voxel element, which reflects the x ray attenuation properties of the structure being imaged. This
property is then recorded as CT numbers from the CT scanner, which can then be converted to
physical densities. Based on 4DCT images, different types of images can be reconstructed since
contouring on every phase of the 4DCT image set can be time consuming. Each of these image
types will reflect the structures differently, especially when tumour motion is involved.

In this chapter, the aim is to study how different reconstructed 4DCT image types, specifically MIP,
AIP, or free breathing image, will affect the resultant CT number of the contoured tumour volume on
the image. Based on the CT number then, the physical density of the contoured tumour volume can
be obtained, and the accuracy of the tumour volume representation can be assessed. Based on this
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study, the image type that best represents the tumour volume can be determined. This is also
important as the values are converted to electron density which is used for dose calculation purposes.

3.3 Materials
3.3.1 CIRS Phantom and CIRS motion control software
The CIRS phantom as seen in Figure 3.2 is used to acquire the images of the tumour moving at
various amplitudes. In all the images acquired, the lung equivalent rod of the CIRS phantom was
equipped with a spherical tumour of 3cm. The lung equivalent rod, attached to an actuator box is
capable of simulating tumour motion in the superior/inferior (SI) direction, anterior/posterior
direction, left/right direction, or a combination of more than one direction. The phantom was set to
only move in the SI direction for 10mm, 20mm , 30mm and 40mm. Another set of images were also
taken for both AP and SI motion, with AP motion set to 10mm, while SI motion is set to 10mm, 20,
30mm, and 40mm.
The CIRS Motion Control (Figure 3.2) allows users to independently control the surrogate motion
(chest or diaphragm motion) and target motion independently. The surrogate motion was controlled
by using a surrogate platform, where the reflective marker block was placed, with motion captured
by the infrared camera. The setup for surrogate motion was in the AP direction, to simulate the chest
wall motion. Cycle time or period of motion can also be selected for motion of the tumour. In this
study, the period selected for the tumour motion 3 seconds, 5 seconds and 10 seconds.

3.3.2 Pinnacle 3 Treatment Planning System.
The treatment planning system used to observe the CT images was the Philips Pinnacle3 treatment
planning system. Images obtained from the CT scanner were exported to the treatment planning
system (Figure 3.3) where Region of Interests (ROIs) can be contoured. On the Pinnacle3 treatment
planning system, there is an anatomic library of the 3D patient organ structure models used in

58

conjunction with the model-based segmentation (MBS) [69] to help radiation oncologists contour
various volumes. It is a threshold based contouring tool that identifies specific threshold values, and
contours the ROIs based on the differences in the gradient between structures. This method did not
impose any constraint on the resultant shape of the delineated object but work only using the
intensities of the image as a threshold [69]. The “auto-contouring” option allowed multiple images
containing the same ROI to be contoured at the same time, reducing the workload of contouring on
all images manually. Based on the ROIs, the average CT number and thus the physical densities
could be determined. The lookup calibration table (Figure 3.4) allows users to quickly determine the
corresponding physical density of the ROIs imaged.

The CT number scale shown on Pinnacle begins from 0 instead of -1000. This is to avoid signed
integers, and thus the final CT number in Hounsfield units needs to be subtracted by 1000 units.

Figure 3.2 : The setup for image acquisition. The CIRS dynamic motion controller, operated through the CIRS Motion Control
Software, supplies motion information, while the Varian RPM system with the Infrared Camera and Marker block captures the motion
and provides a trace respiratory signal.

59

Figure 3.3 : The Pinnacle3 Treatment planning system where various volumes can be contoured on to the images and analysed. The
circular orange line outlines the tumour volume on the AIP image.

Figure 3.4: The CT to physical density lookup calibration table as provided on Pinnacle3 used to convert the CT number to density
values.
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3.4 Methods
Free breathing scans and 4DCT scans of the CIRS Dynamic Thorax phantom (Figure 3.2) were
taken using the Siemens CT scanner at the Illawarra Cancer Care Centre (ICCC). In all the images
taken, the lung equivalent rod of phantom was equipped with a 3cm tumour volume to be imaged.

Helical scans were obtained with the tumour volume set to be moving at various amplitudes, in the
superior/inferior (SI) motion, anterior/posterior (AP) motion with varying periods. Tumours tend to
move more significantly in the SI motion, especially those located at the lower lobes of the lungs
[47, 70]. However, the direction of motion is also dependent on the location and size of the tumour,
as well as the respiratory pattern of the patient. In the lungs, tumour motion is mainly respiration
induced and has been found to be mainly caused by the movement of the diaphragm [47], which is in
the SI direction. Respiratory motion is also the lateral direction. However, this motion is less
significant compared to SI and AP motion.

The slice thickness for the CT images was set at 2mm thick per slices. The tube current (mA) was
modulated such that where there was increased attenuation, the current was increased, and current
was decreased with lower attenuation regions. In this study, we manipulated the SI motion the most,
varying the motion from 10mm (±5mm), 20mm (±10mm), 30mm (±15mm) and the greatest
amplitude being 40mm (±20mm ). AP motion was left at either 0mm or changed to 10mm(±5mm) in
amplitude. These measurements were taken at different periods as well (3 seconds, 5 second and 10
second periods). For 10 second periods, slow gated scan protocols were used. Increasing the tube
current, as well as the scan time will help improve the image quality. However, this will also mean
increased dose to the patient. For this reason, the tube current was automatically modulated to
increase at regions of high attenuation and decrease at areas of low attenuation.

With slow gated scans, the current was at 40mA. Slow gated scans, as the name suggests, required a
longer acquisition time. The couch was moved more slowly through the gantry to ensure that
sufficient time was given to obtain the anatomical cross section of the patient during the respiratory
cycle. A lower current is necessary to reduce radiation dose to the patient. Normal gated scans were
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taken with a current of 80mA. Normal non-gated scans were taken at approximately 200mA. The
normal gated and non-gated scans take the same amount of time to be scanned. Static scans were
also taken for when the phantom is stationary (not moving), where there is no tumour motion.
Table 3.1: The table shows the 4DCT scans acquired corresponding to the amplitude and period used in each of the scan sets.

Name

Period(s)

SI(mm) AP(mm)

CIRS Motion P3s SI 10mm

3

10

0

CIRS Motion P3s SI 20mm

3

20

0

CIRS Motion P3s SI 30mm

3

30

0

CIRS Motion P5s SI 10mm

5

10

0

CIRS Motion P5s SI 20mm

5

20

0

BCRPM 001

5

30

0

CIRS Motion P5s SI 40mm

5

40

0

BCRPM 002

5

40

0

CIRS Motion P10s SI 10mm

10

10

0

CIRS Motion P10s SI 20mm

10

20

0

BCRPM014

10

30

0

CIRS Motion P10s SI 40mm

10

40

0

BCRPM 003

3

10

10

BCRPM 004

3

20

10

BCRPM 005

3

30

10

BCRPM 006

5

10

10

BCRPM 007

5

20

10

BCRPM 008

5

30

10

BCRPM 009

5

40

10

BCRPM 010

10

10

10

BCRPM 011

10

20

10

BCRPM 012

10

30

10

BCRPM 013

10

40

10

62

10

BCRPM014

30

0

The magnitude and period of target motion for all sets of scans taken are seen in Table 3.1. As seen
in the table (Table 3.1), some of the datasets are named starting with ‘CIRS Motion.’, while some
others are named starting with BCRPM. The difference is due to the different time the scans are
taken. Additionally, it was easier to distinguish between the different datasets. All plans with names
starting with ‘CIRS Motion.’ do not have AP motion. With the exception of ‘BCRPM 001’,
‘BCRPM 002’, and ‘BCRPM 014’, all other plans starting with ‘BCRPM…’ had AP motion. An
example of the breathing trace for the tumour motion is shown in Figure 3.5.

Breathing trace with SI and AP motion with a period of 10 seconds
50

displacement (mm)

40

[Y VALUE]mm

30
40mm SI motion
10mm AP motion

20

10

[Y VALUE]mm
start inhale

end exhale

0
0

2

4

6

8

10 12 14 16 18 20 22 24 26 28 30 32 34

Time (seconds)
Figure 3.5 Representation of the tumour motion during respiration on the CIRS phantom with a period of 10 seconds for each
breathing cycle, going from the start of inhalation, to the end of exhalation at 0mm displacement, to the next 0mm displacement. In
this figure, the displacement is in both the Superior/Inferior(in blue) and Anterior/Posterior(in orange) direction. In this study, this
represents the motion for BCRPM 013.

The RPM system was used to monitor and obtain the breathing signal. The reflective marker block
was placed on to the moving platform of the CIRS Dynamic Thorax Phantom, which provides
surrogate breathing motion when placed on the chest wall. The infrared tracking camera emits
infrared light onto the moving marker block, which was then reflected onto the CCD camera detector
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that tracked the motion of the marker block and produced a trace of the respiratory signal. The
retrospectively acquired images are then binned according to 8 different equally spaced phases of the
breathing cycles, at 10%, 23%, 35%, 47%, 60%, 72%, 85%, and 97%. The 8 phases are actually
taken at increments of 12.5%, starting from 10%. However, only whole integers are allowed on the
scanner and the additional decimal is not seen on the different phases. Throughout the text, 23% is
sometimes referred to as 22% as well, and they represent the same phase, which is the phase at
which the tumour is located midway between the two extremes of tumour motion during respiration.
Figure 3.6 shows the how the aforementioned phases make up a respiratory cycle, represented by a
single blue section, the exhalation respiratory section, and a green section, the inhalation respiratory
section.

Figure 3.6 : A representation of the 8 phases in the respiratory cycle in which the images are sorted and binned to for the 4DCT
image set. The Green represents inhalation, while blue represents exhalation.

The CIRS Dynamic Motion Controller (Figure 3.2), through the CIRS Motion Control Software
sends information to the actuator about the range and direction in which the tumour volume is to be
moved as specified by the user. Once this was set up, the CT scanner was used to acquire CT scans
of the phantom.
Images were then DICOM exported onto Pinnacle3 where treatment planning is carried out. ImageJ
was used to produce the MIP and AIP images. The maximum intensity value from every phase of the
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4DCT image set was assigned onto a new CT image at the same location. This was done for all
pixels in the 4DCT image set, effectively forming a new image displaying the maximum intensity
projection (MIP) CT image. The same process was done to produce average intensity projection
(AIP) CT images, but with the average of the pixels instead. The images were then exported onto
Pinnacle3 as well. On all the plans listed in Table 3.1, the tumour volume was delineated on all 8
phases of the 4DCT images, as well as on the AIP and MIP images. Additionally, lung, bone and
soft tissue regions were also delineated. On the static image however, the 3cm sphere used as the
tumour was not present. Instead, for comparison, the soft tissue values for the contoured regions
were used instead for comparison purposes.
On Pinnacle3, the ROIs were selected using the Auto-Contour option, to delineate the regions of
interest. The Auto-Contour thresholding window was set between a lower threshold of 800 and
upper threshold of 4096. As mentioned earlier, to avoid signed integers, the final CT number
displayed on the Pinnacle3 treatment planning system had to be subtracted by 1000 HU. The images
were manually checked as well to ensure that all slice images were properly contoured with the autocontour function.
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Figure 3.7 The CT number of the various volumes as computed on Pinnacle 3 treatment planning system. The final value has to be
subtracted by 1000 HU

As seen in Figure 3.7, Pinnacle assigned the average CT number of the contoured volume for the
tumour volume at each phase, and for lungs, soft tissue, and bone. 1000 HU was subtracted from the
shown CT numbers, and using the calibration table in Figure 3.4, the obtained CT numbers were
converted to physical density values (g/cm3). This is done on an Excel spreadsheet for all the
datasets. Of interest, was the CT number(HU) and density values (g/cm3) tabulated for the AIP and
MIP images, and how well it compared to the free breathing images of the 4DCT image set.

3.5 Results
Table 3.2 shows the resultant CT number, subtracted by 1000HU and the corresponding physical
density values for the moving target at various magnitudes of motion as obtained from the Pinnacle3
treatment planning system.
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Table 3.2: Results comparing the CT number for free breathing, MIP and AIP for the CT number and the corresponding density
values for the moving target within the phantom.

Plan Name
static
CIRS Motion P3s SI 10mm
CIRS Motion P3s SI 20mm
CIRS Motion P3s SI 30mm

CT numbers (HU)
Density (g/cm3)
23%
MIP
AIP
23%
MIP
AIP
-15.2
1.0
0.95
1.04
0.86
-47.4
37.1
-138.2
0.93
1.03
0.64
-74.8
31.3
-358.5
0.92
1.03
0.52
-81.9
31.5
-477.2

CIRS Motion P5s SI 10mm
CIRS Motion P5s SI 20mm
BCRPM 001
CIRS Motion P5s SI 40mm
BCRPM 002

-29.4
-37.2
-84.5
-74.9
9.1

36
36.9
34.6
31.1
32.2

-179.9
-324.2
-404.3
-459.6
-459.7

0.97
0.96
0.92
0.93
1.01

1.04
1.04
1.04
1.03
1.03

0.82
0.68
0.60
0.54
0.54

CIRS Motion P10s SI 10mm
CIRS Motion P10s SI 20mm
BCRPM014
CIRS Motion P10s SI 40mm

-34.4
-36.2
11.3
-103.8

37.7
35.1
37.3
29.7

-186.6
-319.8
-401.8
-456.9

0.97
0.97
1.01
0.90

1.04
1.04
1.04
1.03

0.81
0.68
0.6
0.54

BCRPM 003
BCRPM 004
BCRPM 005

14.7
11.3
3.3

38.5
35.3
28.3

-257.6
-346.7
-371.9

1.02
1.01
1.00

1.04
1.04
1.03

0.74
0.65
0.63

BCRPM 006
BCRPM 007
BCRPM 008
BCRPM 009

14.4
13.6
14.7
7.7

40.1
37
35.2
31.4

-255.6
-382.5
-451.3
-465.1

1.02
1.02
1.02
1.01

1.04
1.04
1.04
1.03

0.75
0.62
0.55
0.54

BCRPM 010
BCRPM 011
BCRPM 012
BCRPM 013

17.4
16.3
14.3
11.6

39
37.2
34.9
33.4

-296.3
-345.1
-451.2
-499.9

1.02
1.02
1.02
1.01

1.04
1.04
1.04
1.03

0.71
0.66
0.55
0.5
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As seen in Table 3.2, the CT numbers of the various reconstructed image types were very different.
The static image produced a CT number of -15.2 HU with a corresponding density of 1.0 g/cm3 for
soft tissue. As there is no motion involved in the static case, the CT number and physical density
values obtained in the static case provides a baseline for comparison when motion is involved for the
various delineated volumes. The static image involved taking non-gated axial CT scans taken with
no respiratory motion set for the tumour motion. When the phantom was imaged for the static scan,
the spherical target volume was not available. As such for the static scan, the reading for soft tissue
is used as a substitute for comparison with the target volume instead since the target and soft tissue
are made of the same material, and thus have the same density.

Based on the results obtained for the CT number and tumour motion as seen in Table 3.2, the
physical density values for the moving target obtained based on the free breathing image obtained at
23% phase, and the MIP dataset is similar, regardless of the period or magnitude of motion. The free
breathing image provided physical density values ranging from the lowest of 0.9 g/cm3 to the highest
of 1.02 g/cm3. The MIP dataset showed values that were either 1.03 g/cm3 or 1.04 g/cm3. In
comparison to the expected 1.0 g/cm3 expected value, the difference was minimal. However, the CT
numbers showed greater differences in values. The CT numbers vary more with the ‘CIRS Motion...’
dataset, while they do not vary so much with the ‘BCRPM...’ set. All ‘CIRS Motion... ’datasets also
appear to have negative values, whereas the ‘BCRPM…’ set showed low positive CT numbers. In
both cases the CT numbers decreased as amplitude is increased.

The AIP image produced showed the lowest CT numbers, with all resultant images producing CT
numbers in the negative range as seen in Table 3.2. The corresponding density values also showed
the lowest values for the target volume, based on the AIP image. As the amplitude of motion is
increased, the corresponding CT number decreased in value. Similarly, the physical density values
decreased as well with decreasing CT number. The CT number for the moving target volume was
calculated to be as low as -499.9 HU to a maximum of -138.2 HU. The density value also ranged
from as low as 0.5 g/cm3 to as high as 0.86 g/cm3.
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Density Comparison with period of 3 seconds
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Figure 3.8 : Density comparison at a period of 3 seconds with amplitudes of 10mm, 20mm, and 30mm, with just SI motion

Density Comparison with Period of 5 seconds
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Figure 3.9: Density comparison at a period of 5 seconds with amplitudes of 10mm, 20mm, 30mm, and 40mm with just SI motion
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Density Comparison with Period of 10 seconds
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Figure 3.10: Density comparison at a period of 10 seconds with amplitudes of 10mm, 20mm, 30mm, and 40mm with just SI motion

Density Comparison with AP motion with Period of 3
seconds
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Figure 3.11 : Density comparison at a period of 3 seconds with amplitudes of 10mm, 20mm, and 30mm for SI motion, and AP motion
of 10mm
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Density Comparison with AP Motion with Period of 5
seconds
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Figure 3.12: Density comparison at a period of 5 seconds with amplitudes of 10mm, 20mm,30mm and 40m for SI motion, and AP
motion of 10mm

Density Comparison with AP motion with Period of 10
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Figure 3.13 : Density comparison at a period of 10 seconds with amplitudes of 10mm, 20mm,30mm and 40m for SI motion, and AP
motion of 10mm

In the graphs shown in Figure 3.8, Figure 3.9, Figure 3.10, Figure 3.11, Figure 3.12¸and Figure
3.13, the graphs compare the different calculated densities of the moving target at different periods
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and magnitudes of motion for MIP, AIP and free breathing, relative to when the target is static.
Figure 3.8,Figure 3.9, and Figure 3.10, compared the density of the moving target with only SI
motion, at period of 3, 5 and 10 seconds, respectively, while Figure 3.11, Figure 3.12, and Figure
3.13 compared the density of the moving target with both AP and SI motion at 3, 5, and 10 seconds
respectively. Based on the graphs, the AIP image represents the target volume with the lowest
density value, in comparison to the other plans. The other plans however showed comparable results
to one another, where the density of the moving target calculated at the different periods and
amplitudes of motion is similar to the measured density when the target is static.
Table 3.3 shows the obtained CT number and corresponding density values different OARs at varying amplitudes and period of
motion obtained from Pinnacle3 for the 4DCT image set, but not of the MIP or AIP datasets.

Plan Name
static
CIRS Motion P3s SI 10mm
CIRS Motion P3s SI 20mm
CIRS Motion P3s SI 30mm

CT numbers (HU)
bones soft tissue lung
369.9
-15.2
-800.4
354.7
-17.2
-800.2
350.5
-18.3
-798.4
336.0
-14.3
-796.2

Density (g/cm^3)
bones soft tissue Lung
1.23
0.99
0.20
1.22
0.98
0.20
1.35
0.98
0.20
1.34
0.99
0.21

CIRS Motion P5s SI 10mm
CIRS Motion P5s SI 20mm
BCRPM 001
CIRS Motion P5s SI 40mm
BCRPM 002

358.1
360.1
362.1
348.4
348.4

-18.3
-16.4
-16.3
-17.4
-17.4

-798.5
-798.3
-799.5
-798.6
-798.6

1.22
1.23
1.23
1.22
1.22

0.98
0.98
0.99
0.98
0.98

0.20
0.20
0.20
0.20
0.20

CIRS Motion P10s SI 10mm
CIRS Motion P10s SI 20mm
BCRPM014
CIRS Motion P10s SI 40mm

360.8
353.1
329.9
349.3

-17.8
-16.6
-16.3
-17.7

-798.4
-798.0
-799.4
-800.5

1.23
1.22
1.21
1.22

0.98
0.98
0.99
0.98

0.20
0.20
0.20
0.20

BCRPM 003
BCRPM 004
BCRPM 005

345.6
366.2
348.9

-16.6
-18.2
-17.3

-799.3
-799.9
-801.2

1.22
1.23
1.22

0.98
0.98
0.98

0.20
0.20
0.20

BCRPM 006
BCRPM 007
BCRPM 008

349.6
356.5
365.8

-17.5
-16.5
-16.9

-800.1
-799.5
-800.2

1.22
1.22
1.23

0.98
0.99
0.98

0.20
0.20
0.20
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BCRPM 009

362.0

-17.7

-801.2

1.23

0.98

0.20

BCRPM 010
BCRPM 011
BCRPM 012
BCRPM 013

350.5
349.8
362.2
343.2

-17.5
-16.7
-17.8
-17.1

-800.3
-799.1
-800.2
-798.7

1.22
1.22
1.23
1.22

0.98
0.98
0.98
0.98

0.20
0.20
0.20
0.20

Comparisons for the bone, soft tissue, and lung CT numbers and corresponding physical density at
the different periods and magnitude of motion was also made as shown in Table 3.3. The values in
Table 3.3 show the CT number for the 4DCT dataset, before they were processed to become AIP or
MIP datasets. They are obtained to observe if there are any changes in the density values as the
amplitude and period of motion of the target volume is manipulated. Regardless, the values should
show little difference as the bone, soft tissue and highlighted section of lungs do not move much
throughout the imaging process. The CT number comparison for the bone, lung, and soft tissue
showed similar numbers throughout the plans. Almost all plans showed the similar physical density
value for bone, lung, and soft tissue.
The bone density for most plans showed similar bone density values, fluctuating between 1.22 g/cm3
to 1.23 g/cm3 compared to the static plan at 1.23 g/cm3. Similarly, the soft tissue density value
obtained for all plans were the same as the static plan, at 0.99cm3, where the values were either 0.98
g/cm3 or 0.99 g/cm3. While the lung density for all plans including the static plan was found to be 0.2
g/cm3. The CT number calculated for the bone, soft tissue and lung delineated volume fluctuated
very little compared to the moving target. In the delineated regions for bone, lung and soft tissue,
there is no significant motion involved, and thus, the result of similar CT number and density values
being measured on the images is as expected.

3.6 Discussion
The difference between the reconstructed images of MIP, AIP and free breathing is obvious based on
the CT numbers and the physical density values.
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Figure 3.14 Compares the difference in images for MIP, AIP, and the 22% phase snapshot, taken from the BCRPM 005 plan from
Pinnacle.

As seen in Figure 3.14 that compares the difference in the delineated volumes, the MIP image has
the clearest representation of the contoured target volume. The MIP image reflects a homogenous
distribution of the same density throughout the contoured volume. The AIP image however showed
less well-defined borders, with higher densities or intensities shown in the middle of the contoured
volume. Since the AIP image is formed based on the average intensity across the same point on all
the 4DCT image set, the resultant image will show the greatest intensity at the point where the target
is most as it travels across the contoured volume. Additionally, as lung volume is being averaged as
well, the resultant image showed a blurred target volume, as well as much lower CT numbers. As the
amplitude of motion is increased, more lung volume was being included in the contoured volume.
This explains the decreased CT number with increasing target motion on the AIP image especially.
However, the AIP image does show a good representation of the average density of the moving
target throughout the respiratory cycle.

Similarly, since the formation of MIP image is based on taking the maximum intensity across all sets
of the 4DCT images, as the target moves across the lung volume, the resultant image was a
homogenous target volume represented on the MIP image. Even as the amplitude of motion was
increased, the image still showed a homogenous image formed. While the corresponding CT number
fluctuated, it did not change more than 10HU at the same period The CT number density of the MIP
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image was the greatest of the different types of reconstructed images. While the CT number of the
contoured target volume was larger than the CT number obtained based on the static target volume,
however the corresponding density of the target volume was similar.

The free breathing image showed CT numbers that fluctuate more significantly than the MIP image
CT numbers, as seen in Table 3.2. However, the density values are comparable to that obtained
based on the free breathing image. The density values however do fluctuate more with increasing
amplitude. The free breathing dataset represents the tumour volume at a particular phase. The free
breathing dataset represents the actual shape and size of the tumour as it moves throughout the lungs
during respiration, compared to MIP and AIP. It should be noted that the static image dataset is not
the same as the free breathing image dataset. The static dataset represents a stationary target,
whereas the free breathing dataset represents the target at approximately the midpoint of its motion.

Based on the results, target motion did not affect the resultant physical density of the delineated
volume. Despite increased magnitude of motion, the physical density of the moving target did not
change. This is seen on the MIP and free breathing image, which remained at around 0.9g/cm 3 or
1.0g/cm3, which is close to the expected 1.0 g/cm3 seen on the static image delineated target volume.
The density of the bone, lung, and soft tissue also remained the same despite the change in
magnitude of motion, as seen in Table 3.3. They do not move significantly during respiration, and
the results shown are as expected.

The density calculated for the moving target based on the AIP image showed less accurate results.
Due to the way the CT numbers are averaged across the motion of the target, an increase in the
magnitude of motion also resulted in more lung volume being averaged for the final average CT
number, resulting in lower CT numbers with increasing target motion. This also resulted in a lower
density value, which is not comparable to the baseline of 1 g/cm3 as provided by the static image.
As addressed earlier, plans starting with “CIRS Motion.. ” were taken at a different time with plans
starting with “BCRPM..”. There was a change in the properties of the CT scanner between the
different acquisition times. To accommodate for this change, a new CT number to density table was
generated, necessary for clinical use. As a result, there is a systematic shift between the “CIRS
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Motion..” plans, and the “BCRPM..” plans, as they both used different calibration tables. However,
corrections have been made to accommodate for this difference, and applying the appropriate CTdensity conversion for the dataset accordingly, meaningful comparison of densities can still be made.
As seen in the comparison for the CT number for the different reconstructed images and the density
values in Table 3.2, the CT numbers acquired for the two different sets of images are quite different,
but the corresponding density values, after applying the appropriate conversion, showed comparable
results.

Different reconstruction methods revealed different CT numbers for the moving target volume.
However, apart from results obtained based on AIP image, the physical density of the target remains
unchanged, despite increasing the magnitude of motion. The increased range of motion results in
more lung volume being averaged together with the tumour volume during image reconstruction for
the AIP image, resulting in the lower CT number, and corresponding density. This implies that the
AIP image may be less suitable and reliable to obtain the CT number for dose calculation purposes.
The CT numbers based on the reconstructed images tend to fluctuate quite significantly. However,
once these numbers were converted into density values on the MIP and free breathing image, they
showed comparable results to the static image. This indicated that the MIP and free breathing image
was suitable to use for representing the tumour volume. The MIP image shows the extent of motion
of the tumour volume, while the free breathing image represents the location, shape and size of the
target volume at approximately midway of the target motion. An accurate representation of the
tumour volume is important in the treatment planning process. However, a more crucial factor to
consider in the treatment planning process is if the dose delivered, is accurately represented based on
the reconstructed images. This will be explored in the next two following chapters of this thesis.

The CT datasets images and comparisons were taken for a phantom, with amplitude of motion that is
constant and regular. The spherical tumour volume in the phantom was 3cm in diameter, moving
periodically with respiratory motion to simulate a stage I NSCLC lung tumour. In the phantom,
OARs are also stationary, with only the tumour moving as programmed. While the CIRS phantom
provides a good simulation of a real patient, it is still relatively simplified compared to clinical
patients.
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In a clinical setting, patients will have irregular respiratory patterns with tumour volumes of varying
sizes and shapes. Additionally, the study was only taken for motion of up to 40mm. Increased
tumour motion may cause image artifacts, which will likely result in inaccuracies of the physical
density values. In a study by Oechsner et al. [71], they found that tumour location has a significant
impact on the dose to the lungs. Additionally, OAR dose based on the MIP image set was found to
be lower compared to the other image datasets. They thus determined that MIP images are less
suitable for OAR dose assessment.

Another factor is also the baseline drift in the breathing signal, where the breathing trace may shift
slightly, resulting in a shift in regular periodic breathing motion. The breathing trace is based on the
external respiratory signal as obtained by the infrared camera and the marker box. If the baseline
drift is large enough, this could result in reduced dose conformity, especially during longer treatment
periods. In a study by Seishin Takao et al. [72], that investigated the baseline shifts/drifts of lung
tumour in SBRT, they found that real time tracking, and careful adjustments of couch or treatment
margins are necessary to ensure that no underdosage occurs. This is especially important with the
methods of using AIP and MIP images sets as they are based on acquired 4DCT image sets.
Therefore, when treating patients using AIP or MIP datasets in treatment planning, motion
management and proper margins are very important such that conformal dose is delivered to the
tumour, and minimal dose is delivered to the OARs on a real patient.

The results obtained here are of a simplified phantom, and a clinical patient would provide a less
predictable and periodic pattern of motion. However, the results do serve as a guide to provide
incremental confidence when applying MIP and AIP methods. The dose delivery and dose
distribution based on MIP and AIP datasets will be explored in the proceeding chapters.

3.7 Conclusion
Contouring the tumour volume on each phase of 4DCT image set can be quite time consuming.
Instead, treatment planning on different reconstructed images based on a single dataset derived from
the 4DCT dataset would be faster. Based on the results obtained, the CT number obtained based on
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the moving target was quite different for MIP, AIP and the free breathing image respectively.
However, upon conversion to physical density, the MIP and free breathing image showed similar
physical density of around 0.9g/cm3 or 1.0g/cm3 for the moving target volume. This is comparable to
the expected 1.0g/cm3 expected as seen on the static image. This holds true, where the physical
density does not change much despite the changing period and magnitude of motion.

The CT number based on the AIP image however showed much lower CT numbers and
corresponding density values in comparison. Additionally, with increasing motion, the density of the
target volume also decreased. Due to the way the image is reconstructed, as magnitude of motion is
increased, more lung volume is being averaged together as well, resulting in the lower average CT
number, and thus lower density, which ranged from 0.5g/cm3 to 0.9g/cm3. However, the delineated
volume does represent the average density of the tumour volume as it moves throughout the
respiratory cycle.

Despite an increase in the magnitude of motion, the physical density of the moving tumour volume
and stationary organs like the bones, soft tissue, and lung do not change. The MIP image shows the
full extent of motion of the moving tumour, while the free breathing image shows the tumour at
approximately midway between the two extremes of the tumour motion. Based on the physical
densities, the MIP and free breathing image dataset could suitably represent the tumour volume.
While the AIP image does not accurately reflect the physical density of the tumour volume for
treatment planning, it does however reflect the average position of the tumour as it moves
throughout the breathing cycle. A more important factor to consider is if using the reconstructed
images for dose calculation and dose delivery would be suitable. Treatment planning is necessary
such that careful and conformal dose delivery can be administered to the patient. As such, in the
proceeding chapters, point dose to the target volume, and the dose distribution to the target volume
based on the different reconstructed images will be discussed.
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4. Dose Delivery Accuracy
4.1 Introduction
The aim of radiation therapy is to eliminate the cancer cells within the patient. This is done by
delivering doses of ionizing radiation to the patient to damage the DNA of the tumour cells. A
typical delivery method involves using a linear accelerator (linac) to deliver a beam of radiation that
can be shaped using multi-leaf collimators and wedges, to ensure conformal radiotherapy is
delivered to the patient. This ensures that radiation is delivered to the tumour cells, while healthy
normal tissues are spared. Dose delivery accuracy is especially important for SABR, where highly
conformal radiation dose is being delivered to the tumour volume, in fewer fractions than
conventional radiotherapy procedures. Additionally, respiratory motion also makes this process more
complicated as it is important to avoid any nearby organs at risk (OAR).

Treatment planning is an essential part of accurate dose delivery. On treatment planning systems,
images are studied, and regions of interest (ROI)s and OARs are contoured. Planning and simulation
enables users to first delineate and identify all the important structures and volumes on the acquired
CT image. On the treatment planning system, the radiation beam can be shaped accordingly to
simulate treatment based on the CT image. Dose calculation algorithms can then be used to
determine the amount of dose delivered to the various volumes of interest, based on a prescribed
dose as determined by the user. The simulation allows users to better observe the dose distribution to
the patient first, before delivering radiation treatment to the patient.

Dose Calculation is necessary to account for all the different physical processes that occur between
the productions of the radiation beam, to how it interacts with the different structures in the body all
the way to the target volume. In an ideal situation, the calculated dose from the treatment planning
system would be the same as the delivered patient dose. However, inevitable deviations exist. This
can be caused by several, or a combination of several factors. This includes the type of dose
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algorithm used, variations in beam delivery, imperfect modelling, patient changes, and input data
imperfections [73].

In this study, because dose is being delivered to a moving target in the lungs, a factor to consider is
how the photons from the beam interact as it travels through the different medium, to the tumour
volume. The lungs are low density, air filled cavities that contain many tiny alveolar air spaces.
During respiration, this structure expands with inhalation, and contracts with exhalation, changing its
composition and thus the density throughout respiration. Due to the presence of the changing airfilled cavities, the lung structure is inhomogeneous. SABR treatment involves the delivery of very
high energy beams, to a small tumour within the low density lungs. In this low-density structure,
attenuation of photons become reduced, leading to greater photon fluence, where secondary
electrons have a greater range, which leads to a phenomenon known as lateral electronic
disequilibrium (LED), which can cause a reduction in the absorbed dose to both the lungs and the
target.

Electron disequilibrium can exist in both lateral and longitudinal directions from the central axis of
the radiation beam. With shallow beam depths, longitudinal electron disequilibrium exists because
the range of the longitudinal secondary electron is simply greater. This is evident in dose build-up
regions, where the dose increases before decreasing exponentially [74]. As the photons travel deeper
in depths or longer distances, attenuation causes fewer photons to travel as the depth increases. This
means that the charged particle (electron) energy increases with depth, until it approaches the
maximum longitudinal range of the secondary electrons, where it runs out of energy [74].

Lateral electron disequilibrium (LED) occurs when the lateral range of electron is larger than the
radius of the beam. This effect causes electrons from the central axis of the beam to be scattered,
resulting in lowered dose along the central axis of the beam. Electrons at the central axis of the beam
scatters beyond the field’s edge, and is not replaced, resulting in lowered dose. The effect of this is
that the dose in the regions can be lower than expected since a dose void occurs [74]. As the energy
of the radiation beam is increased, the effects of LED would become more obvious. More kinetic
energy is transferred to the charged particles, enabling electrons to travel further along its track

80

before depositing its energy, which could result in reduced dose deposition to the central tumour site
despite increased beam energy.

Dose calculation algorithms used therefore must account for this issue and correct for it such that the
calculated dose during treatment planning is in agreement with absorbed dose. On Pinnacle3, the
treatment planning system used in this study, the dose calculation algorithm used is called the
Adaptive Collapsed Cone Convolution Superposition algorithm. This is a model based calculation
algorithm, introduced by Ahnesjo [75], that accounts for the primary photon fluence of the radiation
beam, the projection of the primary photon fluence as it travels through the medium to form a
TERMA (Total Energy Released per Unit Mass) volume, a superposition of the TERMA with dose
kernels to account for tissue heterogeneities on lateral scatter and an electron contamination factor
added after photon dose is computed [76]. This algorithm calculates the primary radiation and the
scatter radiation components, and then superimposes it to produce a final dose distribution to the
affected volume.

A two-dimensional array is used to describe the energy fluence of the radiation beam as it exits the
linac head. The incident energy fluence is then projected through the CT image of the patient and
attenuated using mass attenuation coefficients through ray tracing techniques to form the TERMA
volume. The coefficients are stored in 3-D lookup tables. To account for changing photon energy at
various locations, the mass attenuation lookup table is produced using a weighted sum of several
mono-energetic tables. At each voxel the TERMA is computed using the attenuated energy fluence
along the ray path and mass attenuation coefficient at that density, depth and off-axis angle [76]. The
3-Dimensional dose distribution to the patient is computed by superposition of the TERMA volume
with the energy deposition kernel. The energy deposition kernel represents the spread of energy from
the initial site, throughout the associated volume [76]. With the adaptive convolution superposition
algorithm, at regions where there was higher heterogeneity, the dose was actively computed whereas
at regions were there was more homogeneity, the system interpolated the dose. This helps to reduce
computation time. While Monte Carlo simulation is still considered to be the gold standard for dose
calculation, especially in heterogeneous medium, convolution superposition methods are still a
reliable and faster means of dose calculation.
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Thus, on Pinnacle3, using a dose calculation algorithm, the dose to the target volume can be
determined. As mentioned in previous chapters, to accommodate for the issue of motion and
reducing workload, various image reconstruction methods like using a specific phase from the 4DCT
dataset, MIP or AIP images are used to observe the tumour volume as it moves in the lung. Despite
being obtained from the same 4DCT dataset, the resultant delineated volume on the reconstructed
image will look very different. As seen in Chapter 3 regarding CT number consistency, the CT
numbers are different based on the different reconstructed images. Additionally, on the AIP image,
as magnitude of motion increased, the CT number fluctuated significantly, resulting in different
calculated physical density for the moving target volume. However, on the free breathing image and
the MIP image, despite slight fluctuations in the CT number, the resultant physical density of a
moving target remained the same and comparable to when the target is stationary. It is important that
the tumour volume is accurately represented to ensure dose conformality during treatment planning,
and thus accurate dose delivery as well.

Dose calculation is dependent on the CT number. The CT numbers can be converted to density
values and electron density values of the tissue being imaged, which is necessary for scaling of the
energy deposition kernels [77] used for dose calculation purposes. Even though the CT number and
corresponding density based on the AIP image fluctuated more significantly, it also represents the
average position of the tumour motion. A more meaningful study would be to assess the dose
calculation and dose delivery based on the different types of reconstructed images. In this chapter,
the accuracy of Pinnacle dose as calculated on each dataset will be assessed in comparison to dose
measured on the CIRS phantom on the LINAC under the same conditions.

4.2 Aim
The main aim in this chapter is to determine the accuracy of dose calculation to a point on different
reconstructed 4DCT image types with varying CT numbers, mainly the Maximum Intensity
Projection (MIP) image, the Average Intensity Projection (AIP) image, and the free breathing
image. The purpose is to see how well the various reconstructed image compare to one another for
the dose calculation of a moving tumour within the low-density lungs. As seen in the preceding
chapter, the CT numbers change not only between the different methods of image reconstructions,
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but with increasing magnitude of motion as well. Thus, it would be interesting to see how this affects
the calculated dose, and how well it will compare to measured dose under the same conditions. In
this chapter, we compare the dose delivered to a point within the target volume as seen on the
various 4DCT reconstructed image on the treatment planning system, in comparison to the measured
point dose delivered by the linac to the CIRS phantom.

4.3 Methods
In the previous chapter, the moving target was delineated on the reconstructed images of the 4DCT
dataset, on the MIP, AIP and free breathing image. The images were delineated using the autocontour option on Pinnacle3 treatment planning system. The auto-contour option was set to a lower
threshold of 800 and an upper threshold of 4096. Even though the auto–contour option was used to
delineate the volumes, the images were also manually checked to ensure that the moving target was
properly delineated on all of the reconstructed images. In all the plans, a moving target of 3cm in
diameter was used to represent a stage I small non – small lung cancer (NSCLC). The target was set
to move in the CIRS lung phantom with varying magnitudes of motion and at different periods. In
this chapter, the same sets of images used in chapter 3 were used to determine the point dose
measurements.
This study involved comparing the calculated Pinnacle3 point dose in comparison to the measured
point dose on the CIRS phantom from the Linac. To do this, the pinnacle3 point dose was determined
first. The moving target volume was first determined and delineated on the MIP dataset. A single
anterior field was added with an MLC aperture conformed to the target volume with a 5mm margin
as seen in Figure 4.1. Point dose was calculated for a delivery of 200MU. Once this was determined,
the MIP plan was copied onto both the AIP and Free Breathing dataset using the dynamic planning
tool available on Pinnacle3. For all three MIP, AIP and free breathing datasets, the point dose to the
centre of the target volume with a delivery of 200MU was calculated and recorded.
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Figure 4.1 Single anterior field with MLC aperture with 5mm margin conformed to the target volume, parallel to the target motion

For all the combinations of period and magnitude of motion, as seen in Table 3.1, the point dose to
the MIP, AIP and free breathing dataset was calculated, with the target volume delineated based on
the MIP image. The plans were generated for both 6MV and 10MV photons. On all the plans, a 3 x 3
x 3 mm dose grid with adaptive collapsed cone convolution algorithm was used for dose calculation.
The calculated dose for all plans were then recorded and tabulated in a table.
Once the Pinnacle3 point dose was determined, the point dose to the CIRS phantom from the Linac
was determined next. Using the treatment plans from Pinnacle3, the same settings were applied to the
Linac, to deliver 200MU to the CIRS phantom, at 6MV and 10MV. The MLCs on the Linac helped
to shape a conformal beam onto the phantom, similar to that simulated on Pinnacle3. The target
within the CIRS phantom was also set to move according to the different combinations of period and
magnitude of motion as seen in Table 3.1, and irradiated by the Linac with the same settings set on
the treatment planning system. An ionization chamber was placed within the target volume to
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measure the point dose by the Linac each time the phantom was irradiated. Measurements were then
converted to dose values in cGy, for comparison with the point dose values obtained from Pinnacle3.
Calibration of the ionization chamber is shown in Appendix A(Part A1).

4.4 Results
In the following graphs shown in Figure 4.2,Figure 4.3,Figure 4.4, and Figure 4.5, the graphs show
the point dose values on the reconstructed images, for both calculated Pinnacle point dose, and the
measured point dose. The accompanying tables seen in Table 4.1, Table 4.2, Table 4.3 and Table
4.4, show the point dose values.
Results labelled starting with “Pinnacle..” are the treatment planning system calculated dose, while
results labelled with “Linac..” are measured dose values using the ionization chamber.
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Figure 4.2 point dose comparison for 6MV beam with target moving at 10mm, 20mm, 30mm and 40mm in the SI direction only.
Table 4.1 point dose values with 6MV beam, with target volume moving at varying amplitudes for different reconstructed image,
moving in the SI direction only

6MV beam with SI motion only
Amplitude
10mm 20mm 30mm 40mm
171.2 172.7 172.9 Pinnacle MIP(3 secs)
171.2 173.0 167.8 174.1
Pinnacle MIP(5 secs)
171.6 173.4 168.2 175.8
Pinnacle MIP(10 secs)
Pinnacle AIP(3 secs)
Pinnacle AIP(5 secs)
Pinnacle AIP(10 secs)

172.0
171.2
172.2

174.0
173.8
174.4

173.7 169.8 173.4
170.6 176.1

Pinnacle Free Breathing(3 secs)
Pinnacle Free Breathing(5 secs)
Pinnacle Free Breathing(10 secs)

171.9
170.2
171.7

173.5
172.8
173.7

173.7 170.3 175.0
168.1 176.8

Linac static(3 secs)
Linac static(5 secs)
Linac static(10 secs)

176.2
176.1
176.3

177.7
177.7
177.7

177.8 178.9 179.7
177.1 179.6
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Linac moving(3 secs)
Linac moving(5 secs)
Linac moving(10 secs)

176.4
176.4
176.4

178.0
178.0
178.1

178.1 179.3 180.3
177.5 180.0

Most of the plans showed similar readings when moving at the same amplitude of motion, and at
different periods as seen in the Table 4.1. Only motion at 30mm showed larger differences between
the values at different periods of motion. The measured Linac point dose values fluctuated very little
despite the change in the period of motion.

Figure 4.3 point dose comparison for 6MV beam with target moving at 10mm, 20mm, 30mm and 40mm in the SI direction, and 10mm
in the AP direction for the measured and calculated doses
Table 4.2 point dose values with 6MV beam, with target volume moving at varying amplitudes for different reconstructed image,
moving in the SI direction, with 10mm AP motion

6MV beam with 10mm AP motion and SI motion
Amplitude
10mm 20mm 30mm 40mm
163.4 166.1 167.6 Pinnacle MIP(3 secs)
163.2 165.6 168.2 169.7
Pinnacle MIP(5 secs)
163.1 166.1 168.2 169.5
Pinnacle MIP(10 secs)
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Pinnacle AIP(3 secs)
Pinnacle AIP(5 secs)
Pinnacle AIP(10 secs)

166.5
166.7
166.5

168.5
168.7
168.8

170.2 170.2 171.1
170.2 171.0

Pinnacle Free Breathing(3 secs)
Pinnacle Free Breathing(5 secs)
Pinnacle Free Breathing(10 secs)

166.7
166.6
166.2

168.6
168.0
165.4

169.3 169.4 170.7
168.4 170.2

Linac static(3 secs)
Linac static(5 secs)
Linac static(10 secs)

173.9
173.8
173.7

175.7
175.5
175.5

176.9 176.9 178.1
176.8 177.9

Linac moving(3 secs)
Linac moving(5 secs)
Linac moving(10 secs)

174.0
174.0
173.9

176.0
175.9
175.8

177.3 177.2 178.7
177.3 178.4

With added AP motion of 10mm, both measured and calculated point dose values are found to be
lower compared to the case of only SI motion. However as seen in Figure 4.3 and Table 4.2, even
though the period of motion is changed from 3 to 5 to 10 seconds, the dose values remained similar.
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Figure 4.4 point dose comparison for 10MV beam with target moving at 10mm, 20mm, 30mm and 40mm in the SI direction only for
the measured and calculated doses
Table 4.3 point dose values with 10MV beam, with target volume moving at varying amplitudes for different reconstructed image,
moving in the SI direction only.

10MV beam with SI motion only.
amplitude
10mm 20mm 30mm 40mm
179.9 182.4 182.9 Pinnacle MIP(3 secs)
180.0 182.5 179.6 182.2
Pinnacle MIP(5 secs)
180.3 182.9 180.3 185.6
Pinnacle MIP(10 secs)
Pinnacle AIP(3 secs)
Pinnacle AIP(5 secs)
Pinnacle AIP(10 secs)

178.6
173.1
176.6

180.4
176.8
181.4

178.4 175.0 177.8
177.2 177.9

Pinnacle Free Breathing(3 secs)
Pinnacle Free Breathing(5 secs)
Pinnacle Free Breathing(10 secs)

178.7
170.3
175.5

181.1
177.5
181.4

181.3 177.3 179.9
179.5 183.5

Linac static(3 secs)
Linac static(5 secs)
Linac static(10 secs)

184.7
184.7
184.9

186.8
186.8
187.1

187.1 188.5 189.7
188.0 189.4
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Linac moving(3 secs)
Linac moving(5 secs)
Linac moving(10 secs)

184.6
184.6
184.7

186.6
186.7
186.9

186.5 188.3 189.6
187.9 189.4

At 10MV, the measured and calculated point dose values showed higher values compared to 6MV as
seen in Table 4.3. Calculated point dose values at 10MV with just SI motion at different period, on
the same reconstructed image type, showed slightly more fluctuations as seen in Figure 4.4.
However, except for the difference between the calculated point dose values on the free breathing
image at different periods at 10mm, the dose difference remained under 5cGy.

Figure 4.5 point dose comparison for 10MV beam with target moving at 10mm, 20mm, 30mm and 40mm in the SI direction, and
10mm in the AP direction for the measured and calculated doses
Table 4.4 point dose values with 10MV beam, with target volume moving at varying amplitudes for different reconstructed image,
moving in the SI direction, with 10mm AP motion

10MV beam with 10mm AP motion and SI motion
Amplitude
10mm 20mm 30mm 40mm
175.4 178.2 179.9 Pinnacle MIP(3 secs)
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Pinnacle MIP(5 secs)
Pinnacle MIP(10 secs)

175.4
175.4

178.0
178.2

180.2
180.2

181.7
181.6

Pinnacle AIP(3 secs)
Pinnacle AIP(5 secs)
Pinnacle AIP(10 secs)

175.0
174.5
174.5

177.1
176.5
176.3

177.7 177.0 177.0
177.0 176.9

Pinnacle Free Breathing(3 secs)
Pinnacle Free Breathing(5 secs)
Pinnacle Free Breathing(10 secs)

174.9
174.7
175.3

177.4
177.6
172.0

178.8 179.5 180.7
180.0 180.9

Linac static(3 secs)
Linac static(5 secs)
Linac static(10 secs)

183.6
183.2
183.1

186.0
185.7
185.6

187.6 187.5 188.9
187.4 188.7

Linac moving(3 secs)
Linac moving(5 secs)
Linac moving(10 secs)

183.5
183.0
182.9

185.6
185.4
185.3

187.3 187.2 188.9
187.2 188.6

The measured and calculated point dose values with 10mm AP motion is lower compared to when
AP motion is absent. Based on Table 4.4 and Figure 4.5, changing the period did not significantly
affect the calculated or measured point dose values. The difference between the calculated point
dose values for MIP, AIP and free breathing was also not significantly different at the same
amplitude.

The dose measured was the Linac dose, while the calculated dose on the treatment planning has been
referred to as the Pinnacle3 dose. On Pinnacle3, point dose was calculated for plans with a 3cm target
volume, moving in combination of varying amplitudes and periods of motion. The target moves in
the SI direction varying from 10mm (±5mm), 20mm (±10mm), 30mm (±15mm) and the greatest
amplitude being 40mm (±20mm). AP motion was left at either 0mm or changed to 10mm(±5mm) in
amplitude. These measurements were taken at different periods as well (3 seconds, 5 second and 10
second periods). On all plans for both measured and calculated dose, 200 MU of radiation was
delivered to the target volume.
For most of the plans, for both measured Linac point dose and calculated Pinnacle3 point dose, the
point dose was the same despite changing the period of motion. For example, the calculated point
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dose of the tumour volume on the MIP image at 10mm, for periods of 3 s, 5s, and 10s was
171.2cGy, 171.2cGy, and 171.6cGy respectively. Similarly, the measured Linac point dose at the
same amplitude, was similar despite changing the period of motion. Thus, for both measured and
calculated point dose values, the dose at the same amplitude, but with varying period was averaged
to provide the graphs seen in Figure 4.6,Figure 4.7,Figure 4.8, and Figure 4.9. This was done so
that the difference between the calculated point dose for MIP, AIP and Free breathing, could be
compared to the measured point dose values at different amplitudes.

6MV average point dose comparisons with only SI motion
182.00
180.00
178.00

176.00

Pinnacle MIP(average)

174.00

Pinnacle AIP(average)

172.00

Pinnacle Free Breathing(average)
Linac static(average)

170.00

Linac moving(average)
168.00
166.00
164.00
10mm(cGy)

20mm(cGy)

30mm(cGy)

40mm(cGy)

Figure 4.6 Comparison of the average point dose for different reconstructed images at different amplitudes for both Pinnacle3 and
Linac with only varying SI motion, with a 6MV beam.
Table 4.5: Averaged point dose at 6MV with only SI motion only at different amplitudes and image types.

6MV SI motion only
Average Dose(cGy)

10mm

20mm 30mm 40mm

Pinnacle MIP(average)

171.3

173.0

169.6

175.0

Pinnacle AIP(average)

171.8

174.1

171.4

174.8

Pinnacle Free Breathing(average)

171.3

173.3

170.7

175.9

Linac static(average)

176.2

177.7

177.9

179.7

Linac moving(average)

176.4

178.0

178.3

180.2
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180.00

6MV average Point dose comparison with 10mm AP
motion and varying SI motion

175.00

170.00

Pinnacle MIP(average)
Pinnacle AIP(average)

Pinnacle Free Breathing(average)

165.00

Linac static(average)
Linac moving(average)

160.00

155.00

10mm(cGy)

20mm(cGy)

30mm(cGy)

40mm(cGy)

Figure 4.7 Comparison of the average point dose for different reconstructed images at different amplitudes for both Pinnacle and
Linac, with AP motion of 10mm, and varying SI motion with a 6MV beam.
Table 4.6: Averaged point dose at 6MV with only SI motion and AP motion of 10mm at different amplitudes and image types.

6MV SI and AP motion
Average Dose(cGy)

10mm 20mm

30mm 40mm

Pinnacle MIP(average)

163.2

165.9

168.0

169.6

Pinnacle AIP(average)

166.6

168.7

170.2

171.1

Pinnacle Free Breathing(average)

166.5

167.3

169.0

170.5

Linac static(average)

173.8

175.6

176.9

178.0

Linac moving(average)

173.9

175.9

177.3

178.5
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10MV average dose comparison for different image types
with SI motion only
195.00
190.00
Pinnacle MIP(average)
185.00
Pinnacle AIP(average)
180.00

175.00

Pinnacle Free
Breathing(average)
Linac static(average)

170.00

Linac moving(average)

165.00

10mm(cGy)

20mm(cGy)

30mm(cGy)

40mm(cGy)

Figure 4.8 Comparison of the average point dose for different reconstructed images at different amplitudes for both Pinnacle and
Linac with only varying SI motion, with a 10MV beam.
Table 4.7: Averaged point dose at 10MV with only SI motion only at different amplitudes and image types.

10MV SI motion only
Average Dose(cGy)

10mm

20mm 30mm

40mm

Pinnacle MIP(average)

180.1

182.6

180.9

183.9

Pinnacle AIP(average)

176.1

179.5

176.9

177.9

Pinnacle Free Breathing(average)

174.8

180.0

179.4

181.7

Linac static(average)

184.8

186.9

187.9

189.5

Linac moving(average)(cGy)

184.6

186.7

187.6

189.5
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10MV average dose comparison for different image types with SI and AP
motion
190.00
185.00
Pinnacle MIP(average)
180.00

Pinnacle AIP(average)

Pinnacle Free Breathing(average)

175.00

Linac static(average)
Linac moving(average)

170.00
165.00

10mm(cGy)

20mm(cGy)

30mm(cGy)

40mm(cGy)

Figure 4.9 Comparison of the average point dose for different reconstructed images at different amplitudes for both Pinnacle and
Linac, with AP motion of 10mm, and varying SI motion with a 10MV beam.
Table 4.8: Averaged point dose at 10MV with only SI motion and AP motion at different amplitudes and image types.

10MV average dose comparison SI and AP motion
Average Dose(cGy)

10mm

20mm 30mm 40mm

Pinnacle MIP(average)

175.4

178.1

180.1

181.7

Pinnacle AIP(average)

174.7

176.6

177.2

177.0

Pinnacle Free Breathing(average)

175.0

175.7

179.4

180.8

Linac static(average)

183.3

185.8

187.5

188.8

Linac moving(average)

183.2

185.4

187.2

188.8

Based on the results obtained, for both calculated Pinnacle3 point dose and measured Linac dose at
both 6MV and 10MV, as the amplitude of the superior/inferior SI motion increased from 10mm, to
40mm, the point dose increased as well. Interestingly, the point dose was found to be lower when
anterior/posterior AP motion is introduced, for both the calculated Pinnacle3 point dose and
measured Linac dose. In all the plans, 200 MU of radiation is delivered to the target volume moving
within the CIRS lung phantom. In all cases, the measured point dose delivered by the Linac was
found to be greater than the calculated Pinnacle3 dose. In comparing the values, the calculated point
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dose values from Pinnacle3 was underestimated. The discrepancy between the measured and the
planned dose values were greater for with the 10MV beam results.
At beam energy of 6MV, based on the calculated Pinnacle3 point dose values, there is not a
significant difference between the point dose calculated on the different reconstructed images of
MIP, AIP or the free breathing image as seen in Table 4.5 and Table 4.6. However, most of the plans
showed that the calculated Pinnacle3 point dose on the AIP image was highest in comparison to the
MIP and the free breathing image as seen in Figure 4.6 and Figure 4.7. The MIP image also showed
the lowest calculated point dose with a 6 MV beam delivering 200MU of radiation. In contrast to
this, at beam energy of 10MV, calculated point dose on the MIP image showed the highest
calculated point dose compared to calculated dose on the AIP and free breathing image as seen in
Figure 4.8 and Figure 4.9 while most plans also showed dose calculation on the AIP image
generated the lowest point dose values. Table 4.7 and Table 4.8 both show the calculated and
measured Pinnacle3 dose values when 200MU is delivered with a 10MV beam.

Percentage(%) dose difference was used to observe the difference between the calculated point dose
on Pinnacle, in comparison to the measured dose obtained from the ionization chamber reading.
Here, the percentage difference was considered for the calculated Pinnacle3 point dose on the AIP,
MIP and free breathing dataset, in comparison to the with the measured Linac point dose on the
CIRS phantom. The comparison was made with the phantom moving, simulating free breathing
motion.
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6 MV average % dose difference compared to Linac moving point dose
for SI motion only
6.00
5.00
4.00
MIP(average)

3.00

AIP(average)
2.00

Free Breathing(average)
static(average)

1.00
0.00
10mm

20mm

30mm

40mm

Figure 4.10: 6MV averaged % dose difference with SI motion only comparison at different amplitudes for measured and calculated point dose
Table 4.9: Averaged % dose difference at 6MV with only SI motion only at different amplitudes and image types.

6MV SI motion only average % dose difference
Average % dose difference

10mm

20mm

30mm

40mm

MIP(average) (%)

2.9

2.8

4.9

2.9

AIP(average) (%)

2.6

2.2

3.9

3.0

Free Breathing(average) (%)

2.9

2.7

4.3

2.4

static(average) (%)

0.1

0.2

0.2

0.3
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6 MV average % dose difference compared to Linac moving
point dose for SI and AP motion
7.00
6.00
5.00
MIP(average)

4.00

AIP(average)
3.00

Free Breathing(average)

2.00

static(average)

1.00
0.00
10mm

20mm

30mm

40mm

Figure 4.11: 6MV averaged % dose difference with SI motion and AP motion comparison at different amplitudes for measured and calculated point
dose
Table 4.10: Averaged % dose difference at 6MV with only SI motion and AP motion at different amplitudes and image types.

6MV SI and AP motion only average % dose difference
Average % dose difference

10mm

20mm

30mm

40mm

MIP(average) (%)

6.2

5.7

5.2

5.0

AIP(average) (%)

4.2

4.1

4.0

4.2

Free Breathing(average) (%)

4.3

4.9

4.7

4.5

static(average) (%)

0.1

0.2

0.2

0.3
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10 MV average % dose difference compared to Linac
moving point dose for SI motion only
7.00
6.00
5.00
MIP(average)

4.00

AIP(average)
3.00

Free Breathing(average)
static(average)

2.00
1.00
0.00
10mm

20mm

30mm

40mm

Figure 4.12 10MV averaged % dose difference with SI motion only comparison at different amplitudes for measured and calculated point dose.

Table 4.11: Averaged % dose difference at 10MV with only SI motion only at different amplitudes and image types.

10MV SI motion only average % dose difference
Average % dose difference

10mm 20mm 30mm 40mm

MIP(average) (%)

2.5

2.2

3.5

3.0

AIP(average) (%)

4.6

3.9

5.7

6.2

Free Breathing(average) (%)

5.3

3.6

4.4

4.1

static(average) (%)

-0.1

-0.1

-0.2

0.0
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10 MV average % dose difference compared to Linac
moving point dose for SI and AP motion
7.00
6.00
5.00
MIP(average)

4.00

AIP(average)
3.00

Free Breathing(average)
static(average)

2.00
1.00
0.00
10mm

20mm

30mm

40mm

Figure 4.13 : 10MV averaged % dose difference with SI motion and AP motion of 10mm comparison at different amplitudes for measured and
calculated point dose
Table 4.12: Averaged % dose difference at 10MV with only SI motion and AP motion at different amplitudes and image types.

10MV SI and AP motion only average % dose difference
Average % dose difference

10mm 20mm 30mm 40mm

MIP(average) (%)

4.2

3.9

3.8

3.8

AIP(average) (%)

4.6

4.8

5.3

6.3

Free Breathing(average) (%)

4.5

5.3

4.2

4.2

static(average) (%)

-0.1

-0.2

-0.2

0.0

The % dose different graphs, Figure 4.10, Figure 4.11, Figure 4.12 and Figure 4.13 and
corresponding tables, Table 4.9, Table 4.10, Table 4.11 and Table 4.12, show that the measured
Linac dose was consistently higher than the calculated Pinnacle3 point dose on the AIP, MIP and
free breathing image dataset. Comparison was made with the measured doses, of when the phantom
was static simulating breath hold situations. The difference between the two measured point dose
values at 6MV and 10MV is very small and negligible, at less than 0.3%.
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At 6MV, the % dose difference for MIP was the greatest in most plans, even as the amplitude is
increased as seen in Figure 4.10 and Figure 4.11, while % dose difference for AIP is the least. The
% dose difference also increased when AP motion is added to the plans. At 6MV, the maximum %
dose difference did not exceed 6.2% as seen in Table 4.9 and Table 4.10. The difference between the
% dose difference for the measured point dose between static and moving, which simulates breath
hold and the free breathing respectively, shows minor difference, not exceeding 0.3%, for 6MV and
10MV.

At 10MV, AIP image shows the greatest % dose difference for most of the plans while the % dose
difference for MIP is the lowest in most cases. This was at 6.3% and 4.2% for AIP and MIP
respectively. The % dose difference also increases as AP motion is added to the plans as seen in
Table 4.12, with lower % dose differences recorded without AP motion as seen in Table 4.11. The
10MV plans showed greater discrepancy between the measured and calculated point doses, as seen
in the greater % dose difference values for the 10MV plans.

To summarize, based on the results obtained, the measured Linac point dose on the phantom was
consistently greater than the calculated Pinnacle3 dose, regardless of the beam energy, period, or
magnitude of motion. This is evident in the positive % dose differences comparison between the
calculated Pinnacle dose with the measured Linac point dose. The dose difference shows that dose
calculation by Pinnacle3 underestimates the point dose to the target volume. At 10MV, the difference
between the measured Linac dose and the calculated Pinnacle3 dose increases. The maximum
recorded dose % dose difference was 4.2%, 6.3% and 5.3% for MIP, AIP and free breathing
respectively. At 6MV however, the maximum difference was at 6.2%, 4.2% and 4.9% for MIP, AIP
and free breathing respectively. Additional point dose comparison graphs are shown in Appendix A
(part A2A.2 Point Dose comparisons for Chapter 4).

As the amplitude of motion increased, so did the calculated and measured point doses to the 3cm
tumour volume. On pinnacle3, even though the reconstructed CT image datasets had different CT
numbers, and represented the tumour volume differently, the difference in the calculated dose to the
volume under the same conditions, were not significantly different. The dose difference between the
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calculated Pinnacle3 point dose on the MIP, AIP and free breathing CT dataset, under the same
conditions, did not exceed 5cGy.

4.5 Discussion
The goal was to determine the accuracy of the calculated point dose on the AIP, MIP and free
breathing CT dataset, in comparison to the measured point dose under the same motion settings, to a
3cm moving tumour volume within the lungs. Since the 3 different datasets represent the tumour
volume differently, the goal was also to determine which of the reconstructed dataset was best to use
for dose calculation purposes.
From the results, the calculated Pinnacle3 point dose was underestimated on all the reconstructed CT
datasets, compared to the measured Linac point dose. There could be multiple factors that could
have contributed to this discrepancy. One of the reasons could be the interplay effect, where the
relative motion between the MLC leaves of the Linac and the point the dose is measured can lead to
dosimetric effects, resulting in the higher measured dose. On the treatment planning system, the dose
calculation is dependent on multiple factors, such as the beam energy, the field size, the field
positioning, and the dose calculation algorithm itself. As the beam travels to the small 3cm diameter
moving target volume, it travels through varying densities, from the lower density lung region, into
the higher density target volume. Since it is a relatively small volume, point dose calculation may be
taken close to or within the buildup region, where dose may be lower. Additionally, because the reentrant beam enters the small target volume from a region of higher density, to a region of lower
density, the density variation could result in electron scattering, and thus lateral electron
disequilibrium, resulting in a lower calculated point dose. This situation is further complicated since
the target volume is moving at different amplitudes in the various plans. The relationship between
the planned and measured dose will change depending on the tumour volume, the field size, and the
magnitude of motion.
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MIP image is chosen for target delineation because it sufficiently shows the extent of motion of the
target. In literature, there have been multiple studies [27], [58], [60], [62], that have suggested that
MIP image is suitable for small tumours in the early stages that are not attached to or intersect any
part of the lung walls. According to Bradley et al. [27], MIP images are also considered to be
superior in defining the internal target volume ITV. Compared to the other reconstructed images,
target delineation on the MIP image also provides sufficient volume to accommodate for lateral
electron scatter caused by moving through varying densities to reach the target volume.

In this study, the beam energy used were only 6MV and 10MV. As expected, an increase in the
beam energy showed increased measured and calculated point dose values. The advantage of using
the higher energy beam was that it provided deeper penetration, and greater dose uniformity. This is
because at higher energies, the electrons have a greater electron range, where the more energetic
electrons are able to travel further before being scattered or depositing the dose.

Additionally, the reconstructed images of the MIP, AIP and free breathing CT datasets all represent
the target volume differently. The reconstructed CT datasets have different CT numbers and
corresponding density representation. The target volume on the MIP image is represented as a denser
medium with a higher CT number, while the target volume on the AIP image is represented as a
lower density medium, with a lower CT number.

The point dose difference between the different reconstructed images under the same condition
(period and magnitude of motion) was not significant. However, a noticeable difference is that in
most of the plans, the MIP showed greatest calculated point dose values with a 10MV beam, while at
6MV, the AIP image showed the greatest calculated point dose values. When a higher 10MV beam
is used, the lateral range of electrons increased. To ensure electronic equilibrium is achieved, a
sufficiently large enough volume must be contoured. This study involved using a small 3cm target
volume, moving within the low-density lungs. It is therefore reasonable that at 10MV, dose
calculation on the MIP image, which provides a greater scattering volume, also provided the higher
calculated point dose values.
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The results showed that the point dose also increased as the SI motion was increased. Interestingly,
the dose values were lower when AP motion is introduced. As the amplitude of motion increased, to
encompass the entire target volume, the field size increased as well. This means that more electrons
are able to deposit dose to the delineated volume, and thus the calculated dose value increased on
Pinnacle3. Thus, the calculated dose increases, as field size increases by increasing the motion. In
addition to this, increasing the field size also resulted in less backscatter to the monitor chamber
within the treatment head of the Linac. Therefore, measured dose increased.

Comparing the dose calculated on the MIP, AIP and free breathing image, while there were some
variations in the dose values, the dose difference is not significant between the different
reconstructed CT datasets. Even though each of the reconstructed datasets represented the delineated
volume differently, with different corresponding CT numbers, the dose difference was not
significant. The variation between the calculated point dose on MIP, AIP and free breathing was
smaller. Most plans on Pinnacle for the MIP, AIP and free breathing images showed a dose
difference of less than 5 % in difference. This is within the clinically acceptable limit for dose
accuracy according the ICRU Report no. 24 [78].

The purpose of this chapter was to compare between the calculated pinnacle dose, and the measured
dose. Then comparisons were made for the calculated pinnacle dose on the different types of
reconstructed images, to determine if any one specific 4DCT images were suitable for dose
calculations. Based on the results of the planned pinnacle dose between the different reconstructed
4DCT datasets, there is not a clinically significant difference between the calculated point dose
values. Dose calculation of a small moving tumour, within the low-density lungs can be quite
complex and affected by multiple factors as discussed in this section. It is also clear that the
calculated dose on Pinnacle3 is underestimated in all the plans, compared to the measured point dose
values. There is no clear relationship that suggests that a specific image type was more suitable than
another for dose calculation. Therefore, it would be erroneous to assume that any one specific image
type is suitable for treatment planning and dose calculation for the tumour volume, based on the
point dose measurements. Instead, to better observe and understand the accuracy of dose calculation,
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it would be better to study the dose distribution to the entire volume, by observing the dose volume
histograms, which will be seen in the next chapter.

4.6 Conclusion
Dose calculation to a small 3cm moving target within the low-density lung volume can be
complicated and affected by multiple factors such as beam energy, dose calculation algorithm, field
size, magnitude of motion, and image type used for dose calculation. Calculated point dose values on
all the plans are underestimated on the Pinnacle3 treatment planning system, compared to the
measured point dose values. Increasing the beam energy resulted in increased point dose values.
Increasing the amplitude of motion, and thus the field size of radiation also resulted in an increase in
both measured and recorded point dose values. However, it is difficult to generalize clearly if a
specific reconstructed 4DCT dataset is necessarily suitable for dose calculation based on the point
dose measurements. Dose calculation on the MIP, AIP, and free breathing images for point dose
under the same conditions, was not significantly different from one another when comparing the
point dose for a small target volume moving in a low-density region, representing the lung.

Radiation therapy especially SBRT requires highly conformal treatment planning. Evaluation of the
dose distribution throughout the volume is necessary to determine the validity and quality of the
plan. This will be studied in the following chapter.
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5. Dose Volume Histogram (DVH)
5.1 Introduction
In the previous chapter, point dose measurements to the target volume were measured and
calculated. A more accurate and necessary consideration in radiation treatment planning is the dose
distribution to the entire delineated volume. This can be done by observing the dose volume
histogram.

Dose Volume histogram is a visualization method used to show the 3D dose distribution to the
tumour volume or anatomical structure of interest in a 2D graph. It identifies the amount of dose
delivered to the entire defined or delineated volume of the anatomical structure, presented in the
form of a graph. It presents a range of how much dose is delivered, corresponding to a specific
volume. This allows physicians to do a subjective quantitative assessment of the treatment plans, as
well as comparing the DVHs obtained from multiple treatment plans. The main problem with
observing DVHs however is the inherent loss of spatial information. When 3D dose distribution is
condensed into the 2D DVHs, spatial information is lost as a result.

There are two main types of DVHs, the Differential DVH, and the Cumulative DVH. These DVHs
are usually generated during treatment planning. The Differential DVH is created by grouping the
frequency of voxels within a dose distribution, into a discreet range of dose values [74]. The
resultant graph displays the absolute or relative volume within that discreet dose range. The
Cumulative DVH on the other hand, sums up the frequency of voxel in the dose distribution, and
groups it as cumulative dose values less than a dose range [74], rather than just discreet range of
dose values. Cumulative DVHs are more commonly used in the planning process as well compared
to Differential DVHs. Cumulative DVHs will always start at maximum volume (or 100% volume or
maximum frequency), while Differential DVHs typically start at minimum volume (0% volume or
minimum frequency).
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Figure 5.1 this is an example of the differential DVH (left) and cumulative DVH(right) plans obtained during treatment
planning comparing the DVHs from different image types (MIP, AIP and average summed 8 phases). Note that these
DVHs have been normalized.

As seen from the image, the DVHs graph is a planning evaluation tool that compares the dose
distribution to the volume being treated. From the DVH, users can determine if adequate dose, is
being delivered to the target volume, and hot and cold spots in normal tissues can also be
determined. As seen in the Cumulative DVH graph, the graph labelled MIP PTV shows the best
tumour volume coverage. However, it is also necessary to ensure that normal healthy tissues are
properly protected and not irradiated when choosing the optimum plan for dose delivery.

In observing the DVH, an ideal Differential DVH for treatment would show a sharp well-defined
peak, with a sharp buildup and a quick fall off. In observing the Cumulative DVH for treatment, the
ideal curve would start with a relatively flat line at maximum volume, with a sharp, steep fall off
when maximum dose is delivered to the target volume. This indicates that maximum dosage is being
delivered to the target volume, with minimum normal tissue volume receiving high doses. With
respect to observing the cumulative DVH for normal healthy tissues however, ideally it would be
best if the fall off is quick from the start of the graph, indicating that minimal volume is receiving
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dosage from the radiation treatment. This is usually easier to achieve if the normal healthy tissue is
not overlapping or located further away from the target volume.

.During treatment planning, the different contoured regions will display different DVHs. During
treatment planning on patients, it is important to ensure that while maximal dose is delivered to
patients, organs at risk (OAR) are spared as well such that no complications arise as a result. DVH
comparisons between different contoured volumes such as the Gross Tumour Volume (GTV), the
Planning Target Volume (PTV) will show varying DVHs as well.

Treatment planning based on different image types will also affect the resultant DVHs. The shape
and volume delineated in different image types like Average Intensity Projection (AIP) images and
Maximum Intensity Projection (MIP) images can be quite different from one another. There have
been studies [27, 30, 43, 58, 62] that have indicated MIP images to be suitable for target delineation
during treatment planning for stage I lung cancers for SABR as the whole range of motion of the
tumour in the lungs are delineated throughout the respiration cycle. According to Muirhead et al.
[62], MIP images are both reliable and faster to delineate compared to delineating all phases of the
image sets obtained from the CT scanning. Some studies have also used AIP images are also used
for both target delineation and dose calculations. In the study by Khamfongkhruea et al. [42], the
study performed treatment planning on AIP images, free breathing images and Mid ventilation
images. They concluded that AIP images were sufficient for both target delineation and dose
calculation. Another study by Oechsner et al. [79], that investigated and compared treatment
planning between MIP, AIP and Mid ventilation images, found that AIP images and Mid ventilation
images were suitable for treatment planning, whereas MIP images were not as reliable for dose
accuracy.

Treatment planning can also be done on all phases of the 4DCT images. The tumour volume on each
phase of the respiration cycle can be delineated and the dose to the volume can then be calculated.
The dose to the tumour volume, at every position at the different phases of the respiratory cycle can
be determined. According to Zhang et al. [78], A GTV volume was defined at the end expiration
phase. Contours were then expended to form a clinical target volume (CTV). The same volume is
then used to contour the tumour volume in all phases of the 4DCT image set with an in-house
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deformable image registration algorithm, and defined as the internal clinical target volume (ICTV).
Dose calculation was done on each individual phase. When compared to treatment planning on MIP
or AIP image, this method is more time consuming and labour intensive. However, since dose is
being calculated at each phase throughout the respiratory cycle, it would provide an accurate account
of the amount of dose delivered, at each time and position throughout the respiratory cycle.

Dose calculations based on these different image types could be considerably different. Since the
reconstructed image are represented differently, and dose calculation is dependent on the electron
density, it would be interesting to compare the dose distributions in these volumes to see how the
different plans provided different dose distributions to the volume. Additionally, it would also be
interesting to see how these plans hold up as tumour motion increases in amplitude or when
additional motion is included. In this chapter, the dose volume histogram (DVH) will be used as a
means of comparing the dose distribution to the volume.

5.2 Aim
The third and final aim is to observe the dose distribution to the target volume as calculated on the
different reconstructed images. The dose distribution to the delineated target volume is more
relevant in the treatment planning process for the treatment of the patient. Additionally, since 4DCT
is primarily used for imaging tumours involving motion, it is important that dose calculation on the
reconstructed image is accurate even as the magnitude of motion of the tumour or breathing motion
is increased. This study involves comparison of the dose distribution to the target volume based on
treatment planning on the MIP, AIP and free breathing image compared to the 4DCT image set to
determine the equivalency of the dose as magnitude of motion is increased.
Based on the plans created on Pinnacle3, dose volume histograms (DVH) can be constructed for all
the different image types of MIP, AIP and free breathing for dose distribution comparisons. This can
be achieved by comparing the DVH graphs obtained for 4DCT, against the DVH graphs obtained for
MIP, AIP and free breathing at 23% phase.
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The aim is to study the equivalency of treatment planning based on the MIP, AIP, and free breathing
image, relative to the 4DCT dataset based on the DVH dose distributions graphs. Based on this, it
would be interesting to see if the equivalency still holds, if the magnitude of motion is increased.
This is the main reason why 4DCT imaging is used and it is thus imperative that the reconstructed
images still correctly represent the target volume despite the magnitude of motion.

In this study, comparisons will be made for both differential and cumulative DVHs at 6MV and
10MV beams on the 3cm moving target volume within the CIRS phantom. The DVH graph dose
distributions are calculated and produced on Pinnacle3 for all the plans.

5.3 Methods
In the previous chapters, 4DCT dataset for a moving phantom, the CIRS Dynamic Thorax phantom
at different amplitude and period has been obtained. The 4DCT dataset was exported onto the
Pinnacle3 treatment planning system, where regions of interest were delineated, and the CT number
for various volumes were identified. Point dose values to the target volume was also calculated using
the Pinnacle3 treatment planning system dose calculation algorithm. MIP and AIP datasets were
already reconstructed based on the obtained 4DCT dataset as seen in previous chapters.

In this chapter, the dose to the entire delineated target volume was evaluated by observing the dose
volume histogram, DVH graphs. On the treatment planning system, only a single beam of radiation
was used to irradiate the target volume, with the MLC aperture conformed to the target volume with
a 5mm margin. It should be noted that in typical SABR treatment for patients, more beams are used
during treatment to ensure conformal treatment while simultaneously sparing critical structures,
including skin surfaces.

First, the DVH for the MIP dataset was obtained. The moving target volume was identified using the
auto-contouring option on the treatment planning system. On the MIP dataset, the delineated volume
includes the entire range of motion of the target volume. A single anterior field was added with an
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MLC aperture conformed to the target volume, with a 5mm margin added. 200MU of radiation was
delivered to the target volume at both 6MV and 10MV beam energy on the Pinnacle3 treatment
planning system. Then, Pinnacle3 determines the dose distribution to the delineated volume in the
form of the cumulative and differential DVH graphs. The DVH graph for all the plans with the target
moving in a combination of different magnitude and period was generated. The DVH graph was then
exported onto Microsoft Excel, so that comparisons with other DVH graphs could be made. The
MIP plan sufficiently represents the target volume and the corresponding range of motion. It is due
to this that the MIP plan was copied onto other datasets, to provide the PTV volume. This is why the
MIP plans are copied onto the AIP and FB datasets, to ensure that the same volume can be
delineated on the MIP, AIP and FB datasets for dose distribution comparison.

The MIP plan was then copied onto the AIP dataset using the dynamic planning tool available on
Pinnacle3. On all the remaining plans, 200 MU of radiation was delivered to the moving target
volume at 6MV and 10MV beam energy. On the AIP dataset, the delineated volume was defined by
the MIP image, and the DVH graph was generated and exported onto Microsoft Excel so that
comparisons with other DVH graphs could be made. Similarly, the same process was applied to the
free breathing (23% phase) dataset.

On each phase of the 4DCT dataset, the target volume was also delineated using the auto contour
option on the treatment planning system. This volume makes up the GTV volume only on each
phase of the 4DCT dataset, where only the target volume was contoured on each of the 8 phases.
Again, 200MU of radiation was delivered to the target volume with beam energy of 6MV and 10MV
on Pinnacle 3. The resultant DVH graphs for 8 phases of the 4DCT dataset as seen in Figure 5.2 was
then exported onto Microsoft Excel. The DVH graphs for all 8 phases were added together, and
averaged, to form the Average_GTV DVH graph as seen in Figure 5.3. The dose distribution at each
phase was calculated, summed, and averaged across the 8 phases, to form the resultant
Average_GTV DVH graphs.
Table 5.1 This table summarizes briefly the different volumes delineated on the different images.

Type

Brief Description
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MIP

On the MIP dataset, the target volume with a 5mm margin was contoured.
The delineated volume contains the target volume, as well as the entire range
of motion of the target volume. On the MIP dataset, each voxel represents
the maximum voxel value derived from the 8 phases of the 4DCT dataset.
The MIP DVH represents the dose distribution to this volume.

AIP

For target delineation, the MIP image was copied onto AIP image using the
dynamic planning tool. On the AIP dataset, each voxel represents the
average voxel value derived from the 8 phases of the 4DCT dataset. The AIP
DVH represents the dose distribution calculated based on the AIP image
with the PTV volume defined by the MIP image.

Free

For target delineation, the MIP image was copied onto free breathing

Breathing

image(23% phase dataset) using the dynamic planning tool. The 23% phase
is chosen as it represents the approximate midpoint of the two extremes of
the target motion. The Free Breathing DVH represents the dose distribution
calculated based on the free breathing image, with the PTV volume defined
by the MIP image.

Average_GTV Only the 3cm diameter target, which makes up the GTV volume, was
contoured in each of the 8 phases. The dose to the volume at each phase was
obtained. All 8 DVH graphs were then summed and averaged, to produce the
Avereage_GTV DVH graph. This Average_GTV graph represents the
calculated dose at each phase to the GTV volume, that was then summed and
averaged. This volume also represents the dose distribution to the ITV
region.
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Figure 5.2 The differential DVH for the GTV volume at the different phases of the 4DCT dataset at 10%, 22%, 35%, 47%, 60%, 72%,
85%, and 97% phase. The GTV volume accounts for the target volume alone. These DVH graphs are reconstructed based on data
exported from the Pinnacle Treatment planning system. The information was combined, to form the Average_GTV DVH graph.

Figure 5.3 The Resultant DVH curve formed from averaging the DVH graphs from the 8 phases from the 4DCT dataset, to form the
Average_GTV differential DVH curve.

The tumour volume obtained using 4DCT scan is also known as the ITV region, that is the Internal
Target Volume. This volume accounts for the target volume as well as an internal margin, which
accounts for the variation in shape and size of the tumour as it moves. In SABR treatment, the ITV
volume is essential in treatment planning for evaluation of the treatment plan. Generating the
Average_GTV DVH is similar to obtaining the DVH for the ITV region for the 4DCT dataset. A
quick summary of the different volumes delineated for comparisons are shown in Table 5.1.

Then, the DVH graphs for the MIP, AIP, free breathing, and Average_GTV were put onto one single
graph for comparison, to observe the equivalency of the dose distribution as evaluated on the MIP
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and AIP dataset, in comparison to the dose distribution on the 4DCT dataset. Comparisons are made
to observe how well the dose distribution based on the MIP, AIP and free breathing dataset match
the dose distribution on the 4DCT dataset. The purpose of the comparison is also to observe if the
dose distribution based on the MIP or AIP image, are still comparable, as the magnitude of motion is
increased. In this study, motion was only increased from 10mm, to 40mm in the Superior/Inferior
(SI) direction. Anterior posterior (AP) motion was also added for some of the generated images.

All DVH graphs were generated on the Treatment planning system. Once generated, the information
was exported onto Microsoft Excel or Python so that they can be combined to form a new graph for
comparison. This was necessary as the DVH graphs from the 8 phases of the 4DCT dataset was
added together and averaged to form a new DVH graph. Comparisons were made between the DVH
graphs for MIP, AIP, Free breathing image, Average_GTV and Average_PTV. The final graphs are
normalized such that the comparisons were easier to see. Comparisons were made for the target
volume moving at varying amplitudes and varying magnitudes of motion.

Based on the data provided by the DVH graphs from the 4DCT images and the reconstructed
images, the minimum, maximum and average dose calculated on all the images are also obtained.
This was so that the % dose difference can be compared between the volumes.
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Figure 5.4 A brief flowchart showing the steps taken in generating the DVH graphs for comparison for the various datasets

The flowchart in Figure 5.4 summarises the steps taken to generate the DVH graphs for the various
datasets to compare the dose distribution within the moving target volume.

5.4 Results
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The differential DVH is made up of equal sizes of dose(cGy) bins on the x-axis, and the y-axis
represents the volume(cm3), receiving the corresponding amount of dose. The Cumulative DVH is
also made up of equal sizes of dose(cGy) bins on the x-axis. However, on the cumulative DVH, the
y axis represents the total volume(cm3), receiving greater than or equal to the corresponding dose.

By comparing the DVH of the AIP, MIP and free breathing images on the same graph, the dose
distribution planned on different image types can be seen more clearly. This gives us an indication of
how well the dose distribution is based on the different image types, and how well they compare to
one another. Keeping in mind that the main aim is to compare the equivalency of dose calculation on
the reconstructed AIP, MIP datasets compared to dose calculation on each phase of the 4DCT
dataset. Another aim is to observe if the equivalency holds, as the amplitude or magnitude of motion
is increased.

Comparing the MIP, AIP and Free breathing (23% phase) to the Average_GTV DVH graph

Initially comparisons were just made between the MIP, AIP and Free breathing DVH graphs. During
comparisons, the key points of the graphs can be analysed. That is, in the case of the differential
DVH graph comparisons, to see how the peaks matched each other. In the case of the cumulative
DVH graph comparisons, when the drop off on the graph begins, and how steep the fall off region is
relative to each other. This also provides a basis of the dose distribution homogeneity and accuracy
within the delineated volume.
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Figure 5.5 the differential DVH (a),(c) and cumulative DVH(b),(d)graphs produced, with period of 3 seconds with SI motion of 20mm
for all the graphs at energy of 10MV or 10X. However (c), (d) AP motion of 10mm as well. The DVH shows the comparison of the
DVH produced

As seen in the Figure 5.5, as expected the DVH curve based on the MIP image showed the sharpest
peak on the differential DVH, and the fall off begins the latest, with a significantly steep fall off
slope, compared to the AIP and the free breathing image. From the results obtained, dose calculation
based on the MIP image showed that the minimum, maximum and average dose delivered to the
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delineated volume is greatest compared to the dose calculated based on the free breathing and AIP
image. This is seen at both 6MV and 10MV.

To observe the equivalency of using any of the reconstructed images (MIP, AIP, or free breathing)
for dose calculations, comparisons are made with the Average_GTV DVH graph. Dose calculation
based on each phase of the 4DCT image dataset best represent the dose distribution of the actual
situation and how much dose is delivered to the target volume.

Figure 5.6 The normalized differential and Cumulative comparison for the target volume moving with SI motion of 10mm, with a
period of 3 seconds with a beam energy of 6X.
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Figure 5.7 The normalized differential and Cumulative comparison for the target volume moving with SI motion of 20mm, with a
period of 3 seconds with a beam energy of 6X.

Figure 5.8 The normalized differential and Cumulative comparison for the target volume moving with SI motion of 40mm, with a
period of 10 seconds with a beam energy of 6X.
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Figure 5.9 The normalized differential and Cumulative comparison for the target volume moving with SI motion of 20mm, and AP
motion of 10mm, with a period of 3 seconds with a beam energy of 6X

As seen in the above figures (Figure 5.6,Figure 5.7,Figure 5.8,Figure 5.9) shows the DVH graphs of
the target motion moving at varying amplitudes. The graphs shown have also been normalized by
volume to compare the dose distribution. The graphs have been normalized according to the
differential or cumulative volume respectively, such that the peaks and the fall off regions can be
compared. While not all the DVH graphs are shown here, most of the obtained results show similar
outcomes. As seen in the figures, the DVH graphs based on the MIP image shows the closest dose
distribution equivalency to the Average_GTV graph, representing the dose distribution graph. This is
the case even as the beam energy is increased from 6MV, to 10MV. As the amplitude of the SI
motion is increased from 10mm to 40mm, the DVH curves show similar outcomes as well.

The AIP dataset shows less agreement with the Average_GTV DVH curve. The DVH curve based
on the AIP dataset show a lower dose distribution in comparison to the Average_GTV and MIP
DVH. The DVH peak on the Differential DVH was observed to be more spread out with a wider
calculated dose distribution in the lower range of dosages. The cumulative DVH for the AIP image
also shows that the dose drops off on the graph occurred earlier than the Average_GTV DVH curve.
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The DVH curve based on the FB image showed even greater difference in comparison to the
Average _GTV cumulative and differential DVH curves. The peaks are more spread out, showing
that dose calculation based on the free breathing image has a lower range of dose distribution
delivered to the target volume. In most of the comparisons made at the varying magnitudes of
motion, the DVH curve calculated for the free breathing dataset showed the greatest difference with
the Average_GTV curve. The DVH graph generated for both the AIP and free breathing dataset
showed less equivalency and increasing the magnitude of motion resulted in the DVH curves to
become only slightly less equivalent.

In summary, based on the DVH curve, dose calculation based on the MIP dataset showed the closest
dose distribution equivalency in comparison to the Average_GTV DVH curve. This holds true for up
to 40mm, with superior inferior (SI) motion, even as the beam was increased from 6MV to 10MV.
The AIP dataset and especially the free breathing dataset showed lesser equivalency when
comparing the differential and cumulative DVH curves.

According to the ICRU recommendations in ICRU report 50 [81] and ICRU report 62 [82], the
recommended absorbed dose within the confined volume should be within -5% to +7% of the
prescribed absorbed dose. Using this as a guide to see how well the reconstructed MIP, AIP and free
breathing dataset compared to the 4DCT dataset, the % dose difference between the reconstructed
images, and the 4DCT dataset is compared. The mean % dose difference in most cases shows
relatively good agreement, where the % dose difference falls within the -5% to +7% range, despite
the DVH curves not matching well in some cases.

It is noted that there is a more recent and relevant report, the ICRU report 83 [83], which provides
updated guidelines based on the ICRU reports 50 and 62, and ICRU report 91 [84] which provides
fundamentals and a framework for stereotactic radiation therapy (SRT). Both report 83 and 91
provides standardized procedures and techniques for prescribing recording and implementing IMRT
and SRT, or in the context of this thesis, SABR treatment for patients, as a useful reference to
practitioners. However, the recommendations by reports 50 and 62 are still relevant to the study and
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results taken based on the CIRS Phantom provide a useful indication to what should be considered a
clinically significant dose variation.
Table 5.2 The minimum, maximum and average dose acquired based on the DVH graphs generated on Pinnacle for a moving target.

Name
type min
138.2
CIRS Motion p3 SI 10mm GTV
MIP
144.7
AIP
137.1
3 second period with SI
motion of 10mm
22%
128.4

Pinnacle Calculated DVH dose
6X
10X
max
average min
max
average
176.0
157.1
131.7 179.2
155.4
176.0
160.4
138.2 181.4
159.8
175.9
156.5
123.0 179.1
151.0
175.8
152.1
128.4 181.3
153.3

CIRS Motion p3 SI 20mm GTV
MIP
AIP
3 second period with SI
motion of 20mm
22%

137.4
146.1
136.3
126.5

178.9
178.8
177.7
178.8

158.2
162.5
157.0
152.6

131.3
139.3
121.0
127.2

184.5
184.3
182.1
180.6

157.9
161.8
151.5
153.9

CIRS Motion P10s SI 10mm GTV
MIP
AIP
10 second period with SI
motion of 10mm
22%

96.2
145.9
126.4
129.7

176.1
176.1
176.2
176.1

136.1
161.0
151.3
152.9

90.3
139.4
119.9
116.7

182.8
181.6
179.4
178.3

136.5
160.5
149.6
147.5

CIRS Motion P10s SI 40mm GTV
MIP
AIP
10 second period with SI
motion of 40mm
22%

134.1
146.2
130.9
129.6

181.4
182.4
177.1
180.1

157.7
164.3
154.0
154.9

125.9
140.7
122.1
120.8

188.3
188.3
178.2
185.6

157.1
164.5
150.2
153.2

GTV
6X
6X

131.5
132.8
129.1
126.8

176.5
176.7
172.9
176.4

154.0
154.8
151.0
151.6

133.8
138.6
121.1
119.9

184.5
184.8
178.7
183.3

159.2
161.7
149.9
151.6

BCRPM 003
3 second period with SI
motion of 10mm and AP
motion of 10mm

GTV
MIP
AIP
22%

128.2
129.4
128.2
125.9

173.6
173.7
171.3
170.2

150.9
151.6
149.8
148.0

129.3
134.0
123.7
121.4

179.2
179.4
175.9
177.0

154.3
156.7
149.8
149.2

BCRPM 004
3 second period with SI
motion of 20mm and AP
motion of 10mm

GTV
MIP
AIP
22%

130.4
131.7
129.3
128.1

176.2
176.4
172.8
172.7

153.3
154.1
151.0
150.4

131.6
136.3
124.7
121.2

181.9
183.3
178.5
178.4

156.8
159.8
151.6
149.8

BCRPM 002
5 second period with SI
motion of 40mm
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BCRPM 005
3 second period with SI
motion of 30mm and AP
motion of 10mm

GTV
MIP
AIP
22%

130.0
134.8
132.2
126.6

178.3
177.4
174.7
173.8

154.1
156.1
153.4
150.2

127.7
139.4
125.3
123.1

185.2
184.3
179.3
180.7

156.4
161.9
152.3
151.9

BCRPM 006
5 second period with SI
motion of 10mm and AP
motion of 10mm

GTV
MIP
AIP
22%

121.4
128.4
128.1
125.9

173.7
173.8
171.1
171.3

147.6
151.1
149.6
148.6

114.5
131.8
122.4
120.2

179.1
179.5
175.2
175.8

146.8
155.6
148.8
148.0

BCRPM 011
10 second period with SI
motion of 20mm and AP
motion of 10mm

GTV
MIP
AIP
22%

105.2
131.9
129.3
69.2

175.0
176.7
172.8
169.0

140.1
154.3
151.0
119.1

100.5
135.4
127.0
61.2

182.7
183.5
178.5
172.4

141.6
159.5
152.8
116.8

Table 5.3 The % dose difference between the reconstructed 4DCT dataset of MIP, AIP and free breathing, against the Average_GTV
for the minimum, maximum and average dose acquired based on the DVH graphs generated on Pinnacle for a moving target.

% dose difference with Average_GTV
6X
10X
max
average
min max
average
0.0
0.0
0.0
0.0
0.0
0.0
-2.1 -5.0
-1.2
-2.8
0.0
0.4
6.6
0.1
2.8
0.1
3.2
2.5
-1.2
1.4

Name
type
CIRS Motion p3 SI 10mm GTV
MIP
3 second period with SI motion AIP
of 10mm
22%

min
0.0
-4.7
0.8
7.1

CIRS Motion p3 SI 20mm GTV
MIP
3 second period with SI motion AIP
of 20mm
22%

0.0
-6.3
0.9
8.0

0.0
0.0
0.7
0.1

GTV
MIP
AIP
22%

0.0
-51.7
-31.5
-34.8

GTV
MIP
AIP
22%

0.0
-9.0
2.4
3.4

CIRS Motion P10s SI 10mm
10 second period with SI motion
of 10mm
CIRS Motion P10s SI 40mm
10 second period with SI motion
of 40mm

0.0
-2.7
0.8
3.5

0.0
-6.0
7.9
3.2

0.0
0.1
1.3
2.1

0.0
-2.4
4.0
2.6

0.0
0.0
0.0
0.0

0.0
0.0
-15.8 -54.4
-9.7 -32.8
-10.7 -29.2

0.0
0.7
1.9
2.4

0.0
-17.5
-9.6
-8.0

0.0
-0.6
2.3
0.7

0.0
0.0
-4.2 -11.7
2.4
3.0
1.8
4.0

0.0
0.0
5.3
1.4

0.0
-4.7
4.4
2.5
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GTV
6X
6X

0.0
-1.0
1.8
3.6

0.0
-0.2
2.0
0.0

0.0
-0.5
1.9
1.5

0.0
-3.6
9.5
10.4

0.0
-0.2
3.2
0.7

0.0
-1.6
5.8
4.8

BCRPM 003
3 second period with SI motion
of 10mm and AP motion of
10mm

GTV
MIP
AIP
22%

0.0
-1.0
0.0
1.8

0.0
-0.1
1.3
2.0

0.0
-0.5
0.7
1.9

0.0
-3.6
4.4
6.1

0.0
-0.1
1.9
1.3

0.0
-1.6
2.9
3.3

BCRPM 004
3 second period with SI motion
of 20mm and AP motion of
10mm

GTV
MIP
AIP
22%

0.0
-1.0
0.9
1.8

0.0
-0.1
1.9
2.0

0.0
-0.5
1.5
1.9

0.0
-3.6
5.2
7.9

0.0
-0.7
1.9
1.9

0.0
-1.9
3.3
4.4

BCRPM 005
3 second period with SI motion
of 30mm and AP motion of
10mm

GTV
MIP
AIP
22%

0.0
-3.7
-1.7
2.6

0.0
0.5
2.0
2.5

0.0
-1.3
0.4
2.6

0.0
-9.2
1.9
3.6

0.0
0.4
3.2
2.4

0.0
-3.5
2.6
2.9

BCRPM 006
5 second period with SI motion
of 10mm and AP motion of
10mm

GTV
MIP
AIP
22%

0.0
-5.7
-5.4
-3.7

0.0
-0.1
1.5
1.4

0.0
0.0
-2.4 -15.1
-1.4 -6.9
-0.7 -5.0

0.0
-0.2
2.2
1.9

0.0
-6.0
-1.3
-0.8

BCRPM 011
10 second period with SI motion
of 20mm and AP motion of
10mm

GTV
MIP
AIP
22%

0.0
-25.4
-22.9
34.2

0.0
-1.0
1.3
3.4

0.0
0.0
-10.1 -34.7
-7.8 -26.4
15.0 39.0

0.0
-0.5
2.3
5.6

0.0
-12.6
-7.9
17.5

BCRPM 002
5 second period with SI motion
of 40mm

The table, Table 5.2, shows the minimum, maximum and average dose values obtained based on the
DVH graphs produced on Pinnacle for the 4DCT dataset in comparison to the MIP, AIP, and free
breathing(labelled as 22% in the table) dataset. In most cases as seen in the results above, Table 5.3,
the % dose difference observed for the average dose falls within the -5% to +7% dose difference.
The exception occurs only with the case of BCRPM011, and CIRS Motion P10 SI 10mm. In both
cases, the target volume was moving at a period of 10 seconds, with the amplitude of motion in the
SI direction being 20mm and 10mm respectively.
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Figure 5.10 This shows the Differential and cumulative DVH curve for a target volume moving with a period of 10 seconds, with
amplitude of motion in the SI direction of 10mm.

As seen in Figure 5.10,with the curve in red, representing the Average_GTV graph, on the
differential DVH graph, there are small bumps in the curve, indicating that lower dose values are
being delivered to very small volumes. This thus results in lower minimum dose, and thus a lower
average dose as well for the 4DCT average_GTV dataset.
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Figure 5.11 This shows the Differential and cumulative DVH curve for a target volume moving with a period of 10 seconds, with
amplitude of motion in the SI direction of 20mm and 20mm in the AP direction.

In the figure, Figure 5.11, the Average_GTV differential DVH shows that the minimum dose to the
volume is lower than both the AIP and MIP minimum dose, while the maximum dose is also greater
than MIP, AIP, and free breathing curves. Based on this result, the Average_GTV has a greater
range of dose distribution to the moving target volume.

In the two cases where the % dose difference between the Average_GTV volume, against the MIP,
AIP, and Free breathing volume exceeded the -5% to +7% dose difference, both had slow scanning
protocols set in place, where the period of motion was 10 seconds, with SI motion being at 10mm(
Figure 5.10) and 20mm (Figure 5.11) respectively. The discrepancy observed in the greater % dose
difference could be due to the slow scan protocol implemented for the target volume moving with
the 10 second period. Slow CT scan results in better ITV target delineation, however there could also
be a loss of resolution and contrast because of motion blurring. This may have contributed to the
discrepancy, and thus a greater difference in the calculated dose distribution seen.

It is unlikely that the period of motion or the slow scanning protocol is the cause of the discrepancy.
In a similar setting, where the period of motion was 10 seconds, and the amplitude of motion was at
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40mm, the % dose difference for the average dose all fell within the ICRU guideline. The
Differential and cumulative DVH curve seen in Figure 5.12, show that the Average_GTV curve
match the MIP and AIP curve well. The % dose difference for the Average dose to the moving target
volume as seen in Table 5.3 for CIRS p10 SI 40mm, at 6MV and 10MV are within the acceptable
range as well.

Figure 5.12 This shows the Differential and cumulative DVH curve for a target volume moving with a period of 10 seconds, with
amplitude of motion in the SI direction of 40mm.

The results also show that increasing the beam energy to 10MV results in increased dose to the
target volume. However, similar patterns are observed using 6MV and 10MV beams on the target
volume. When comparing the % dose difference for the average dose between the Average_GTV
DVH and the MIP, AIP and free breathing average dose, dose calculation on the reconstructed
images are still comparable.

However, results here for the DVH curves are obtained by dose calculation on Pinnacle for a small
3cm in diameter moving target, moving at a maximum amplitude of 40mm in the SI direction, with a
single 6MV or 10MV beam. In a clinical setting, deformable registration is necessary to track the
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delivered dose to the target volume during respiration. Additionally, more beams will also be used
for more conformal treatment to the target volume while simultaneously avoiding OARs. Additional
comparisons for the dose distribution at various magnitude of motion and periods are shown in the
Appendix B.

5.5 Discussion
Evaluation of the dose distribution to a moving target within heterogeneous condition can be
complicated and requires careful evaluation. In the context of SABR treatment for NSCLC lung
cancers, 4DCT imaging techniques are commonly used to track the moving tumour and how it
changes throughout the respiration cycle within the lungs. The 4DCT images are commonly used
and reconstructed to form MIP, AIP or free breathing images, as a quicker means to determine the
dose distribution to the moving target volume. Treatment planning on the reconstructed dataset
would be far less time consuming. This chapter focusses on determining the equivalency of
treatment planning and dose calculation on the MIP, AIP or free breathing datasets, in comparison to
treatment planning on the 4DCT dataset. This chapter also focuses on determining if the equivalency
of dose calculation on the reconstructed dataset matches the 4DCT dataset as the magnitude of
motion is increased.

In this study, the dose calculation algorithm used was the same for all the images, which is the
Pinnacle3 dose calculation algorithm, which accounts for the lung inhomogeneity correction. Dose
calculation to a small field, moving within a low-density volume is a complex and complicated
process. Different dose distribution due to electronic disequilibrium, due to varying densities and
beam energies can occur. However, this study, dose calculation on all 4 datasets, the 4DCT, the MIP,
AIP and free breathing dataset uses the same dose algorithm for dose comparison. Therefore, the
comparison is mainly focused on whether dose calculation on the MIP, AIP or free breathing dataset,
is comparable to the 4DCT dataset.
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Only beam energies of 6MV and 10MV were used in this study. Higher energy beam allows the
photons to travel deeper while simultaneously sparing healthy normal tissue. Additionally, dose
uniformity in radial dose is also improved. However, at higher energies, a concern is that lateral
electron disequilibrium can occur which can lead to under dosing. This effect is especially
pronounced in low density mediums like the lungs, where the increased energy results in increased
electron range, especially in low density mediums like the lungs, which can result in loss of dose to
the central axis of the beam if the field size is not large enough. Lateral disequilibrium will show in
the form of a broadened DVH graph at higher energy as seen in a study by Wang et al [85], that
compared the DVH graphs obtained when using 6MV beam and 15 MV beam. Fortunately, based on
the obtained results, at 10MV, lateral electronic disequilibrium is less significant. However at higher
beam energies, like at 15MV [85], or 18MV [86], electronic disequilibrium can occur and the results
can be affected greatly.

In evaluating the dose distribution, observing the DVH graph gives a good visual way to determine
the accuracy of dose calculation. The Average_GTV DVH curve represents most closely the amount
of dose delivered to the target volume. As such it was used as a standard of comparison to for dose
calculation based on the MIP, AIP and free breathing datasets. The main problem with DVH graph
observation however, is the lack of spatial information.

The Dose distribution seen for the Average_GTV DVH, results from taking the average dose
distribution from all 8 phases and averaging the DVH formed by the 8 phases. While the volume
delineated on each phase is smaller, the density representation at each phase for the GTV volume,
was similar. Since dose calculation is based on the electron density, and the GTV volume contains
only the target volume, the MIP image DVH is expected to have similar DVH curves to the Average
GTV DVH. This was seen in the results as well.

Equivalency between using MIP, AIP free breathing, vs 4DCT.

The focus of this study was to evaluate the effect of treatment planning on reconstructed images,
when the magnitude of motion for the small target is increased. The dose distribution was evaluated
mainly for target motion in the superior inferior SI direction, and the anterior posterior AP direction.
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These represent motion due to the diaphragm and the chest wall respectively. For dose calculation,
the physical size of the PTV volume used for dose calculation is the same.

The MIP image suitably represented the extent of motion of the moving target volume, which is why
the MIP image is copied on to the AIP and Free breathing datasets for target delineation. According
to Bradley et al. [27], and Muirhead et al. [62], MIP images provide reliable enough representation
of the volumes for target delineation, for early stage 1 NSCLC lung tumours. While the physical
delineated target volume size is the same on MIP, AIP and free breathing datasets, under the same
condition, the main difference of the three different reconstructed dataset, is the voxel/density
representation. Based on the shape of the DVH graph alone, the dose distribution calculated based
on the MIP image is closest to the Average_GTV curve. Dose calculation based on the AIP image
showed lesser agreement, while dose calculation on the free breathing image shows the least
agreement.

In contrast, since calculating the dose on the AIP and free breathing image, there are also lung
densities within the delineated volume, the calculated dose is thus lower as well. Since each pixel on
the AIP dataset represents the average density across the 4DCT dataset, this resulted in a lower
calculated dose. However, the AIP dataset showed more accurately the mean position of the target
volume. Some studies have shown that while target delineation based on the MIP image for early
stage tumour is relatively accurate, dose calculation based on the MIP image may be less accurate
compared to dose calculations on other image types [30, 62]. Another study by Khamfongkhruea et
al. [42] demonstrated that the AIP image and free breathing image could both be used for target
delineation and dose calculation however caution should be taken with target delineation using free
breathing images. Studies that have shown AIP images are suitable for dose calculation purposes
[42, 71, 87]. However in the study by Khamfogkruea et al. [42], they have also shown that using a
Mid-ventilation image is also suitable for dose calculation. This is the position of the tumour, at the
mean tumour position. The phase at which this occurs is used for dose calculation. The 23% phase
free breathing image is the closest to this location. It is possible that due to the increased magnitude
of motion, as well as velocity, artifacts occur, affecting the image quality. This can be caused by
incorrect binning or missing images in the original 4DCT image set, which then occurs in the
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reconstructed AIP image as well, leading to inaccurate dose calculations based on the delineated
volume.

The maximum, minimum, and average dose obtained for the DVH volume was also compared. The
average dose to the delineated volume, based on the MIP, AIP and free breathing dataset, was in
agreement to the 4DCT dataset. The percentage dose difference shows that there is a negative
difference between the MIP dataset and the 4DCT dataset, while for the free breathing and AIP
dataset, most of the % dose difference show a positive % dose difference. This indicates that dose
calculation based on the MIP image, may result in slight underdosage to the moving target volume,
while dose calculation based on the AIP and free breathing resulted in a positive % difference. The
positive % dose difference implies that dose calculation based on the AIP and free breathing dataset
result indicate that the maximum and average dose is greater, the minimum dose is also greater in
value.

In short, dose calculation based on the MIP image provided a narrower range of dose distribution,
while dose calculation based on the AIP and free breathing dataset provided a wider range of dose
distribution. However, the DVH graphs for this study show that dose calculation based on the MIP
image provides better homogenous dose distribution relative to the DVH provided when planning on
the 4DCT dataset. In contrast to this, the DVH based on the AIP and free breathing image, showed
less homogeneity and accuracy.

Equivalency as amplitude is added.

The DVH curves shape showed that as amplitude is increased from 10mm, to 40mm, which is the
greatest amplitude for target motion in this study, the AIP and free breathing DVH curves became
less equivalent. Electronic disequilibrium is a factor to consider as well. Dose was calculated for a
heterogeneous situation, where a single radiation beam was delivered to a 3cm moving target within
the low-density lung equivalent phantom. As the beam travels through the different medium to the
target volume, the small target volume size may not provide a sufficient volume for the buildup
region, and thus maximum dose is delivered outside of the volume, resulting in electronic
disequilibrium.

132

As the amplitude of motion was increased, the size of the volume increases, and there is more
variation in the delineated volume, where more lung volume including the target volume is
delineated. On the reconstructed image of the AIP and Free breathing images, as motion amplitude
increased, the discrepancy between dose calculation on the AIP and free breathing image, in
comparison to the 4DCT dataset increased.

Despite lacking in the homogeneity in the DVH curves comparison, the results obtained show that
the dose calculation on the AIP and free breathing images are still comparable, following the ICRU
guidelines. It is likely that increasing the manitude of motion beyond 50mm, will result in much
greater discrepancy where treatment planning based on the different reconstructed images becomes
unsuitable. However, target motion exceeding 50mm is rare. However this is also dependent on the
target volume location and size. Tumour volumes that are closer to the diaphragm experience greater
motion due to respiration [48, 88]. Smaller tumour volumes are more mobile, whereas more
advanced tumours are unlikely to exceed 10mm motion during normal breathing [48].
In a clinical situation, a patient’s lung is different from the phantom lung. Even though the phantom
is meant to simulate a patient’s lung as closely as possible, the respiratory motion and lung and
tumour geometry will not be as uniform as represented on the phantom. The purpose of this study
was to evaluate if treatment planning and dose calculation on 4DCT represented images provided
accurate or acceptable results. Based on the calculations done on Pinnacle, for motions of up to
40mm, the DVH graphs show that the MIP image provides reliable comparison to treatment
planning on 4DCT dataset. The AIP and free breathing dataset provides reliable comparisons as
well, according to the ICRU guidelines, when comparing the maximum and minimum dose to the
target volume. However, at larger amplitudes, the results may show something else. Based on the
DVH graph trend, at higher amplitudes, the AIP and free breathing dataset may show more
discrepancy and thus become unsuitable to be used for treatment planning.

Typical radiotherapy methods incorporate multiple radiation beams to deliver a uniform dose
distribution to the target volume while sparing the surrounding healthy tissue [88]. Incorporating
multiple beams during treatment will result in more conformal accurate radiation delivery with less
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discrepancies and errors. Additionally, in a clinical setting, patients that undergo SABR treatment for
NSCLC lungs have irregular breathing patterns. The study here is based on the CIRS phantom,
where target motion is periodically and consistently at the selected magnitude of motion. On the
patient, the geometry and shape of the lung, as well as the magnitude of motion can be quite
different and unpredictable on each patient. When target motion is irregular, even though 4DCT
images provide important temporal and spatial information on the moving targets, the method is still
limited by current technology [90]. Careful treatment planning on individual patients must be carried
out to ensure that conformal treatment is administered to each patient without oversimplified
assumptions.

Therefore, in a clinical setting, it is prudent to not generalize that one specific reconstructed image
type is suitable for treatment planning. Each patient will present with a different problem and with
different target and lung geometries, for NSCLC patients. Careful treatment planning methods
should be carried out to ensure accurate, homogenous treatment is delivered to the patient. This is
especially important since SABR treatment involves delivering high dosages of radiation in small
fractions.

5.6 Conclusion
The main aim of the study was to determine the equivalency of treatment planning on the MIP, AIP
and free breathing dataset compared to treatment planning on the 4DCT dataset. Comparing the
DVH curves, treatment planning based on the MIP showed the best equivalency in terms of
homogeneity and accuracy. Upon comparing the % dose difference, dose calculation on the AIP and
free breathing image, the mean dose to the delineated volume still fall within the ICRU
recommendations.

Another aim of the study was to determine if the reconstructed dataset of the MIP, AIP and free
breathing dataset, was suitable for dose calculation as the amplitude of motion was increased.
Comparing the DVH curve for the MIP dataset against the 4DCT dataset, good agreement can be
seen even when the magnitude of motion is increased up to 40mm. However, the AIP and free
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breathing DVH graph shape became less equivalent to the 4DCT dataset, where the homogeneity
became worse with increasing amplitude of motion. However, when comparing the % dose
difference, the mean dose to the delineated volume still fall within the -5% and +7% dose range
relative to the 4DCT dataset mean dose. However, the maximum amplitude of motion for the target
was only at 40mm. At higher amplitudes, this may not be the case.

The results were obtained based on dose calculation on Pinnacle, based on 4DCT images obtained
from the CIRS lung phantom, with a perfectly spherical 3cm target volume moving at a constant rate
within the phantom. In a clinical situation, treatment planning for a patient would involve patients
with a range of different health levels where the geometry of the lung and target volume would vary.
Additionally, the target volume may not move as periodically as seen on the phantom as well.
Therefore, for the results to be clinically significant, studies involving real patients need to be carried
out. SABR for stage I NSCLC cancer is a highly conformal method of treatment for lung cancers.
Careful treatment planning is necessary to ensure that the target tumour volume is properly
irradiated, and the OARs of the patient is protected.

The results provide incremental confidence and guidance in applying MIP or AIP related 4DCT
procedures and dose delivery SABR treatment for stage I NSCLC cancer.
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6. Summary and Conclusion.
In this study, we evaluated the difference of treatment planning on different reconstructed images
based on 4DCT images of a moving target within a low-density lung volume. This was done by
imaging the CIRS lung phantom with a spherical moving target placed to simulate the motion of the
tumour moving as a patient breathes. Motion of the tumour was mainly driven by diaphragm motion,
with greatest motion typically in the superior-inferior direction. In this study, 4DCT images were
taken of the CIRS phantom moving in the superior-inferior direction only, and when there was both
superior-inferior and anterior-posterior motion. Superior inferior motion was increased in 10mm
increments, from 10mm, 20mm, 30mm and finally 40mm. Images were taken at increasing
magnitudes of motion to study the accuracy of the image representation, and the accuracy of
treatment planning and dose calculation on the different reconstructed images.

The purpose of treatment planning and dose calculation being done on these reconstructed images
was to reduce the time involved in the treatment planning process. A 4DCT image set contains many
images in many phases of breathing. Treatment planning based on all phases of breathing would be
tedious and time consuming. Thus, a few different methods of image reconstruction were applied to
the images to evaluate the accuracy of planning treatment for a moving target. In carrying out the
study, 3 main research questions are answered.

1) What impact does scan analysis techniques on 4DCT datasets (ie : MIP, AIP, specific 4DCT
phase) have on CT number?
The varying scan techniques resulted in different 4DCT datasets, with varying CT numbers. CT
numbers were converted to physical density, which was obtained through an established relationship
on Pinnacle3, the treatment planning system. The number was then converted to electron density for
dose calculation. Despite varying CT numbers, the physical density of the delineated target volume
on the MIP image and the free breathing image showed consistent and accurate physical density
representation of the volume even up to 40mm magnitude of motion. The AIP image however
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showed both lower CT number and physical density representation of the same delineated volume
compared to the MIP and free breathing image. Therefore, despite varying CT numbers, the density
values were comparable for the MIP and free breathing image. This is important as dose calculation
is density dependent.

2) What impact do different CT numbers derived from reconstructed 4DCT datasets have on dose
calculated to a point?

Based on the MIP, AIP and free breathing image, all with varying CT numbers, the dose to a point
was calculated on the different reconstructed 4DCT dataset. The dose calculation algorithm was the
same on all image datasets, using the Pinnacle3 calculation algorithm to determine the point dose. It
was found that based on point dose measurements, dose calculation on the AIP image was the most
accurate, whereas dose calculation on the MIP image and free breathing image was more accurate at
10MV. The measured point dose to the phantom was found to be consistently greater than the
calculated Pinnacle3 point dose, regardless of the image type. The discrepancy between the measured
and calculated dose became more significant at 10MV. However, in radiotherapy, a more relevant
and accurate assessment of the treatment plan would be to evaluate the dose to the entire volume,
and not just the point dose measurements. Thus, the dose distribution to the delineated volume is
evaluated as well.

3) What impact does the different CT numbers derived from reconstructed 4DCT datasets have on
dose calculated to a moving target volume?

The dose distribution to the delineated volume was evaluated on the MIP, AIP and free breathing
datasets by observing the DVH. It was found that the MIP image which represents the highest CT
number and density on the image was most suitable for comparison for the dose to the delineated
volume. This is true at both 6MV and 10MV beam energy, even as the magnitude of motion was
increased. As the magnitude of motion was increased, the accuracy of the dose distribution
deteriorated on the AIP and free breathing image, in comparison to dose calculation on the 4DCT
dataset. However, in comparing the % dose difference, the mean dose difference in most cases for
the AIP and free breathing dataset still fell within an acceptable range. At higher magnitudes of
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motion beyond 50mm, this may not be the case, and using AIP or free breathing dataset for dose
calculation may be less suitable. Dose calculation to a moving target is complicated and can be
affected by multiple factors. It is difficult to generalize that a specific image is more suitable than
another.

The results here are obtained for a lung equivalent phantom, with a small spherical target moving
within the lungs. This is to simulate a stage 1 non-small cell lung cancer (NSCLC) scenario within
the patient. The simulation is for a target moving with a maximum SI motion of 40mm, within the
low-density lungs that is 3cm in diameter, and is not attached to the diaphragm, or bronchi of the
lungs. The difference and potential over simplification of this study is that clinical patients will
present with tumour shapes of varying shapes and size, with irregular breathing patterns, compared
to the observed results in this study. Evaluation of the dose distribution to real patients will give a
better indication of the accuracy of the results found in this study. However, this study provides a
basis of assessing patients with stage 1 NSCLC through simulations on the CIRS phantom, and dose
calculations carried out on the Pinnacle treatment planning system.

The results obtained for the simplified phantom geometry and motions may help provide incremental
confidence and guidance in applying varying scanning techniques like MIP or AIP related 4DCT
procedures, especially in dynamically moving treatment planning and radiation dose delivery for
lung radiotherapy SABR treatment.
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8. Appendices
Appendix A

A.1 Calibration for Ion Chamber for measurements of dose to a point
in Chapter 4.
The ionization chamber here was calibrated for measurement of the dose to a point in the target
volume moving within the CIRS lung phantom. Measurements were recorded and compared to
calculated point dose values from Pinnacle, with simulated target motion at the same magnitude of
motion. The setup is seen in Figure A.1.

From literature, dmax usually occurs at 1.5cm, and 2.1cm for 6MV and 10MV respectively. Using
this method, the charge reading obtained can be converted into dose reading. From our study, dmax at
6X occurs at 1.5cm depth, while for 10X, it occurs at approximately 2.4 cm depth.

Figure A.1 Setup of the water tank with the ionisation chamber attached to the traversing mechanism
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Ionization chamber readings are measured in terms of charge (nC). To convert it to dose (cGy), we
take the measured reading as a ratio of the charge at dmax, multiplied with any necessary correction
factor, to obtain the dose values.
𝑑𝑜𝑠𝑒(𝑐𝐺𝑦) =

𝑐ℎ𝑎𝑟𝑔𝑒(𝑛𝐶)
x 100 (𝑐𝐺𝑦) x 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟.
𝑐ℎ𝑎𝑟𝑔𝑒 𝑎𝑡 𝑑𝑚𝑎𝑥(𝑛𝐶)

The correction factor is necessary because measurements were taken at separate times. 2 different
types of correction factors are applied to the measured data. During the setup for each day, the start
and end reading did not vary significantly. However, when comparing the start and end
measurements for different days, difference is relatively significant. To account for this, a correction
factor(k1) is applied to the second set of data. This is done by taking the sum of the measurements at
the start, and end of the first setup, divided by the sum of the measurements at the start and end of
the second setup:
K1 (6X) =

(−0.992)+(−0.992)+(−0.992)+(−0.993)
(−0.971)+(−0.969)+(−0.972)+(−0.971)

= 1.022
(−1.072)+(−1.072)+(−1.073)+(−1.072)

K1(10X) = (−1.052)+ (−1.052)+(−1.055)+(−1.055)
= 1.018
Another correction used is the correction used for temperature and pressure differences. For the first
setup, the temperature and pressure is at 22.4°C (295.55 K) and 99.95kPa respectively. With the
second setup, the temperature and pressure is at 23.1°C(296.25K) and 100.62kPa the respectively.
Using ideal gas law to relate these two variables, we get the relationship that PV = nRT, where P is
pressure, V is the volume, n is the number of moles, R is the gas constant, and T is the temperature.
𝑃1 𝑉 = 𝑛𝑅𝑇1
𝑃2 𝑉 = 𝑛𝑅𝑇2
The volume does not change, and number of moles as well as the gas constant, R, are constants in
this case. To relate the data from first setup to second setup, a correction factor 𝑘𝑇,𝑃 can be applied
such that
𝑘𝑇,𝑃 𝑃1 𝑉 = 𝑃2 𝑉
Such that
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𝑘𝑇,𝑃 =

𝑇1 𝑃2
𝑇2 𝑃1

The value of 𝑘𝑇,𝑃 , thus works out to be 1.0043. This correction factor is only applied to the data
obtained from the first setup.
Now converting the obtained charge values to dose involves taking it as a ratio to the charge at
dmax, multiplied by the correction factors where necessary.
𝑑𝑜𝑠𝑒(𝑐𝐺𝑦) =

𝑐ℎ𝑎𝑟𝑔𝑒(𝑛𝐶)
x 100 (𝑐𝐺𝑦) x 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟.
𝑐ℎ𝑎𝑟𝑔𝑒 𝑎𝑡 𝑑𝑚𝑎𝑥(𝑛𝐶)

For example:
At 6X, for the first setup for CIRS Motion P3s SI 10mm, the measured charge is -1.83 nC. The
measurement at dmax for 6X obtained from the water tank measurement is -1.043nC. Applying the
𝑘𝑇,𝑃 correction as well gives a value of 176.21cGy.

A.2 Point Dose comparisons for Chapter 4
The calculated dose to a point values as determined on Pinnacle treatment planning system for the
MIP, AIP, Free Breathing, in comparison with the measured static and measured moving point dose
values. This A.2 sub chapter will show the point dose value comparisons for 3 seconds, 5 seconds,
and 10 seconds, at the various amplitudes of target motion.
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6 MV Dose comparison with SI motion only at 3 seconds
180.00
178.00

dose(cGy)

176.00
MIP(3 secs)

174.00

AIP(3 secs)
172.00

Free Breathing(3 secs)

170.00

static(3 secs)

168.00

moving(3 secs)

166.00
10mm

20mm

30mm

amplitude
Figure A.2 Point dose comparison at 6MV with only SI motion at 10mm, 20mm, and 30mm, at period of 3 seconds, based on various
reconstructed images.
Table A.1 Point dose (cGy) comparison with only SI motion for 10mm, 20mm and 30mm for the various reconstructed images with a
period of 3 seconds

MIP(3 secs)
AIP(3 secs)
Free Breathing(3 secs)
static(3 secs)
moving(3 secs)

CIRS MOTION P3
10mm(cGy) 20mm(cGy) 30mm(cGy)
171.20
172.7
172.9
172.00
174.0
173.7
171.90
173.5
173.7
176.21
177.66
177.75
176.41
178.00
178.14
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6 MV Dose comparison with SI motion only at 5 seconds

dose(cGy)

182.0
180.0
178.0
176.0
174.0

MIP(5 secs)

172.0
170.0
168.0
166.0
164.0
162.0
160.0

AIP(5 secs)
Free Breathing(5 secs)
static(5 secs)
moving(5 secs)

10mm(cGy)

20mm(cGy)

30mm(cGy)

40mm(cGy)

amplitude
Figure A.3 Point dose comparison at 6MV with only SI motion at 10mm, 20mm, 30mm, and 40mm at period of 5 seconds, based on
various images.
Table A.2 Point dose (cGy) comparison with only SI motion for 10mm, 20mm, 30mm and 40mm for the various reconstructed images
with a period of 5 seconds

MIP(5 secs)
AIP(5 secs)
Free Breathing(5 secs)
static(5 secs)
moving(5 secs)

CIRS Motion P5
10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy)
171.2
173.0
167.8
174.1
171.2
173.8
169.8
173.4
170.2
172.8
170.3
175.0
176.07
177.71
178.91
179.73
176.36
178.04
179.30
180.31
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dose(cGy)

6 MV Dose comparison with SI motion only at 10 seconds

182.0
180.0
178.0
176.0
174.0
172.0
170.0
168.0
166.0
164.0
162.0

MIP(10 secs)
AIP(10 secs)
Free Breathing(10 secs)
static(10 secs)
moving(10 secs)

10mm(cGy)

20mm(cGy)

30mm(cGy)

40mm(cGy)

amplitude
Figure A.4 Point dose comparison at 6MV with only SI motion at 10mm, 20mm, 30mm, and 40mm at period of 10 seconds, based on
various reconstructed images.
Table A.3 Point dose (cGy) comparison with only SI motion for 10mm, 20mm, 30mm and 40mm for the various reconstructed images
with a period of 10 seconds

MIP(10 secs)
AIP(10 secs)
Free Breathing(10 secs)
static(10 secs)
moving(10 secs)

CIRS Motion P10
10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy)
171.6
173.4
168.2
175.8
172.2
174.4
170.6
176.1
171.7
173.7
168.1
176.8
176.31
177.66
177.09
179.63
176.36
178.09
177.48
180.02
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6 MV Dose comparison with SI and AP motion at 3 seconds
180.0

dose(cGy)

175.0
MIP

170.0

AIP
165.0

Free Breathing
static

160.0

moving

155.0
10mm(cGy)

20mm(cGy)

30mm(cGy)

amplitude
Figure A.5 Point dose comparison at 6MV with SI motion and AP motion at 10mm, 20mm and 30mm at period of 3 seconds, based on
various reconstructed images.
Table A.4 Point dose (cGy) comparison with SI motion and AP motion for 10mm, 20mm and 30mm for the various reconstructed
images with a period of 3 seconds

amplitude
MIP
AIP
Free Breathing
static
moving

BCRPM 003,004,005
10mm(cGy)
20mm(cGy)
30mm(cGy)
163.4
166.1
167.6
166.5
168.5
170.2
166.7
168.6
169.3
173.85
175.72
176.94
174.00
176.01
177.28

153

6 MV Dose comparison with SI motion at 5 seconds

dose(cGy)

182.0
180.0
178.0
176.0
174.0

MIP(5 secs)

172.0
170.0
168.0
166.0
164.0
162.0
160.0

AIP(5 secs)
Free Breathing(5 secs)
static(5 secs)
moving(5 secs)

10mm(cGy)

20mm(cGy)

30mm(cGy)

40mm(cGy)

amplitude
Figure A.6 Point dose comparison at 6MV with SI motion and AP motion at 10mm, 20mm, 30mm, and 40mm at period of 5 seconds,
based on various reconstructed images.
Table A.5 Point dose (cGy) comparison with SI motion and AP motion for 10mm, 20mm, 30mm and 40mm for the various
reconstructed images with a period of 5 seconds

amplitude
MIP
AIP
Free Breathing
static
moving

BCRPM 006,007,008,009
10mm(cGy)
20mm(cGy)
30mm(cGy)
40mm(cGy)
163.2
165.6
168.2
169.7
166.7
168.7
170.2
171.1
166.6
168.0
169.4
170.7
173.76
175.47
176.89
178.07
173.95
175.91
177.24
178.66
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6 MV Dose comparison with SI and AP motion at 10 seconds
180.0

175.0

MIP

170.0

AIP

Free Breathing
165.0

static
moving

160.0

155.0

10mm(cGy)

20mm(cGy)

30mm(cGy)

40mm(cGy)

Figure A.7 Point dose comparison at 6MV with SI motion and AP motion at 10mm, 20mm, 30mm, and 40mm at period of 5 seconds,
based on various reconstructed images.
Table A.6 Point dose (cGy) comparison with SI motion and AP motion for 10mm, 20mm, 30mm and 40mm for the various
reconstructed images with a period of 10 seconds

amplitude
MIP
AIP
Free Breathing
static
moving

BCRPM 010,011,012,013
10mm(cGy)
20mm(cGy)
30mm(cGy)
40mm(cGy)
163.1
166.1
168.2
169.5
166.5
168.8
170.2
171.0
166.2
165.4
168.4
170.2
173.71
175.47
176.79
177.92
173.85
175.81
177.28
178.41

10MV point dose comparison
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10MV Dose comparison with SI motion at 3 seconds
188.00
186.00

Dose(cGy)

184.00
MIP(3 secs)
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180.00

Free Breathing(3 secs)
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176.00
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20mm(cGy)

30mm(cGy)

amplitude
Figure A.8 Point dose comparison at 10 MV with only SI motion at 10mm, 20mm and 30mm at period of 3 seconds, based on various
reconstructed images.
Table A.7 Point dose (cGy) comparison with only SI motion for 10mm, 20mm and 30mm for the various reconstructed images with a
period of 3 seconds at 10MV

CIRS MOTION P3
amplitude
10mm(cGy) 20mm(cGy) 30mm(cGy)
MIP(3 secs)
179.90
182.4
182.9
AIP(3 secs)
178.60
180.4
178.4
Free Breathing(3 secs)
178.70
181.1
181.3
static(3 secs)
184.71
186.80
187.09
moving(3 secs)
184.62
186.61
186.52
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10MV Dose comparison with SI motion at 5 seconds
195.0

190.0

dose(cGy)

185.0
MIP(5 secs)

180.0

AIP(5 secs)
175.0

Free Breathing(5 secs)
static(5 secs)

170.0

moving(5 secs)

165.0
160.0
10mm(cGy)

20mm(cGy)

30mm(cGy)

40mm(cGy)

amplitude
Figure A.9 Point dose comparison at 10 MV with only SI motion at 10mm, 20mm, 30mm, and 40mm at period of 5 seconds, based on
various reconstructed images.
Table A.8 Point dose (cGy) comparison with only SI motion for 10mm, 20mm, 30mm and 40mm for the various reconstructed images
with a period of 5 seconds at 10MV

amplitude
MIP(5 secs)
AIP(5 secs)
Free Breathing(5 secs)
static(5 secs)
moving(5 secs)

CIRS MOTION P5
10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy)
180.0
182.5
179.6
182.2
173.1
176.8
175.0
177.8
170.3
177.5
177.3
179.9
184.71
186.85
188.51
189.70
184.57
186.71
188.32
189.61
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10MV Dose comparison with SI motion at 10 seconds
195.0
190.0

dose(cGy)

185.0

MIP SI only
AIP SI only

180.0

Free Breathing SI only

175.0
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170.0
165.0
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30mm(cGy)

40mm(cGy)

amplitude
Figure A.10 Point dose comparison at 10 MV with only SI motion at 10mm, 20mm, 30mm, and 40mm at period of 10 seconds, based
on various reconstructed images.
Table A.9 Point dose (cGy) comparison with only SI motion for 10mm, 20mm, 30mm and 40mm for the various reconstructed images
with a period of 10 seconds at 10MV

amplitude
MIP(10 secs)
AIP(10 secs)
Free Breathing(10 secs)
static(10 secs)
moving(10 secs)

CIRS MOTION P10
10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy)
180.3
182.9
180.3
185.6
176.6
181.4
177.2
177.9
175.5
181.4
179.5
183.5
184.90
187.09
187.96
189.37
184.71
186.90
187.86
189.42
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10MV Dose comparison with SI and AP motion at 3 seconds
190.0

185.0
MIP(3 secs)
180.0

AIP(3 secs)
Free Breathing(3 secs)

175.0

static(3 secs)
moving(3 secs)

170.0

165.0
10mm(cGy)

20mm(cGy)

30mm(cGy)

Figure A.11 Point dose comparison at 10MV with SI motion and AP motion at 10mm, 20mm and 30mm at period of 3 seconds, based
on various reconstructed images.
Table A.10 Point dose (cGy) comparison with only SI motion and AP motion for 10mm, 20mm and 30mm for the various
reconstructed images with a period of 3 seconds at 10MV

BCRPM 003,004,005
amplitude
10mm(cGy) 20mm(cGy) 30mm(cGy)
MIP(3 secs)
175.4
178.2
179.9
AIP(3 secs)
175.0
177.1
177.7
Free Breathing(3 secs)
174.9
177.4
178.8
static(3 secs)
183.63
185.99
187.62
moving(3 secs)
183.53
185.60
187.29
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10MV Dose comparison with SI and AP motion at 5 seconds
195.0
190.0
185.0

MIP(5 secs)
AIP(5 secs)

180.0

Free Breathing(5 secs)
static(5 secs)

175.0

moving(5 secs)

170.0
165.0
10mm(cGy)

20mm(cGy)

30mm(cGy)

40mm(cGy)

Figure A.12 Point dose comparison at 10MV with SI motion and AP motion at 10mm, 20mm, 30mm, and 40mm at period of 5 seconds,
based on various reconstructed images.
Table A.11 Point dose (cGy) comparison with only SI motion and AP motion for 10mm, 20mm,30mm and 40mm for the various
reconstructed images with a period of 5 seconds at 10MV

amplitude
MIP(5 secs)
AIP(5 secs)
Free Breathing(5 secs)
static(5 secs)
moving(5 secs)

BCRPM 006,007,008,009
10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy)
175.4
178.0
180.2
181.7
174.5
176.5
177.0
177.0
174.7
177.6
179.5
180.7
183.24
185.75
187.48
188.92
183.05
185.41
187.19
188.92
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10MV Dose comparison with SI and AP motion at 10 seconds
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dose(cGy)
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175.0
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170.0
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Figure A.13 Point dose comparison at 10MV with SI motion and AP motion at 10mm, 20mm, 30mm, and 40mm at period of 10
seconds, based on various reconstructed images.
Table A.12 Point dose (cGy) comparison with only SI motion and AP motion for 10mm, 20mm,30mm and 40mm for the various
reconstructed images with a period of 10 seconds at 10MV

MIP(10 secs)
AIP(10 secs)
Free Breathing(10 secs)
static(10 secs)
moving(10 secs)

BCRPM 010,011,012,013
10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy)
175.4
178.2
180.2
181.6
174.5
176.3
177.0
176.9
175.3
172.0
180.0
180.9
183.10
185.55
187.43
188.73
182.91
185.31
187.19
188.63
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Appendix B
Differential Volume Histogram Graph Comparisons for Chapter 5.
This subchapter will show the remaining DVH graphs not included in Chapter 5. The comparisons
will show the DVH curve for MIP, AIP and Free breathing images. In the graphs shown below, the
curve labelled 23% phase represents the DVH curve for the Free breathing image. The following
DVH curves show the comparison of the DVH curves between the Average_GTV graph, in
comparison to the reconstructed MIP, AIP and Free breathing images, at various amplitudes, and
periods of motion with beam energies of 6MV and 10MV.

Figure B.14 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving in the SI direction at 40mm with a period of 5 seconds with 6MV beam energy.
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Figure B.15 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 10mm in the SI direction and 10mm in the AP direction, with a period of 3 seconds with 6MV beam energy.

Figure B.16 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 20mm in the SI direction and 10mm in the AP direction, with a period of 3 seconds with 6MV beam energy.
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Figure B.17 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 30mm in the SI direction and 10mm in the AP direction, with a period of 3 seconds with 6MV beam energy.

Figure B.18 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 10mm in the SI direction and 10mm in the AP direction, with a period of 5 seconds with 6MV beam energy.
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Figure B.19 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 20mm in the SI direction and 10mm in the AP direction, with a period of 10 seconds with 6MV beam energy.

Figure B.20 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 10mm in the SI direction with no AP motion, with a period of 3 seconds with 6MV beam energy.
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Figure B.21 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 20mm in the SI direction with no AP motion, with a period of 3 seconds with 6MV beam energy.

Figure B.22 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 10mm in the SI direction with no AP motion, with a period of 5 seconds with 6MV beam energy.

166

Figure B.23 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 10mm in the SI direction with no AP motion, with a period of 10 seconds with 6MV beam energy.

Figure B.24 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 40mm in the SI direction with no AP motion, with a period of 10 seconds with 6MV beam energy.
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10 MV Energy

Figure B.25 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 40mm in the SI direction with period of 5 seconds with 10 MV beam energy

168

Figure B.26 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 10mm in the SI direction and 10mm in the AP direction, with a period of 3 seconds with 10MV beam energy.

Figure B.27 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 20mm in the SI direction and 10mm in the AP direction, with a period of 3 seconds with 10MV beam energy.
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Figure B.28 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 30mm in the SI direction and 10mm in the AP direction, with a period of 3 seconds with 10MV beam energy.

Figure B.29 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 10mm in the SI direction and 10mm in the AP direction, with a period of 5 seconds with 10MV beam energy.
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Figure B.30 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 20mm in the SI direction and 30mm in the AP direction, with a period of 10 seconds with 10MV beam energy.

Figure B.31 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 10mm in the SI direction with no AP motion, with a period of 3 seconds with 10MV beam energy.
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Figure B.32 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 20mm in the SI direction and no AP motion, with a period of 3 seconds with 10MV beam energy.

Figure B.33 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 10mm in the SI direction and no AP motion, with a period of 5 seconds with 10MV beam energy.
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Figure B.34 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 10mm in the SI direction and no AP motion, with a period of 10 seconds with 10MV beam energy.

Figure B.35 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with
target motion moving 40mm in the SI direction and no AP motion, with a period of 10 seconds with 10MV beam energy.

